[go: up one dir, main page]

WO2020175681A1 - Layered body for skin adhesion and method for producing same - Google Patents

Layered body for skin adhesion and method for producing same Download PDF

Info

Publication number
WO2020175681A1
WO2020175681A1 PCT/JP2020/008363 JP2020008363W WO2020175681A1 WO 2020175681 A1 WO2020175681 A1 WO 2020175681A1 JP 2020008363 W JP2020008363 W JP 2020008363W WO 2020175681 A1 WO2020175681 A1 WO 2020175681A1
Authority
WO
WIPO (PCT)
Prior art keywords
layer
laminate
skin
support
silicone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2020/008363
Other languages
French (fr)
Japanese (ja)
Inventor
米山 聡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Corp
Original Assignee
Fujifilm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Corp filed Critical Fujifilm Corp
Publication of WO2020175681A1 publication Critical patent/WO2020175681A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/02Adhesive bandages or dressings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B32LAYERED PRODUCTS
    • B32BLAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B25/00Layered products comprising a layer of natural or synthetic rubber
    • B32B25/20Layered products comprising a layer of natural or synthetic rubber comprising silicone rubber

Definitions

  • Laminate for skin application and method for producing the same
  • the present disclosure relates to a laminate for skin application and a method for producing the same.
  • Examples of the skin-adhesive laminate include wound dressings and transdermal preparations, which have various uses.
  • a pressure-sensitive adhesive layer containing a carboxylic acid ester for sticking to a living body and one of the pressure-sensitive adhesive layers in the thickness direction is used.
  • Absolute value of A laminated body for sticking to a living body is disclosed.
  • Japanese Patent Laid-Open No. 2106-10 2 2 2 23 there is described a film base material, a first adhesive layer on the bottom surface of the film base material, and a second adhesive layer on the upper surface of the film base material. And a first release liner and a second release liner attached to each of the first adhesive layer and the second adhesive layer of the protective film member.
  • the following medical protective film material is disclosed.
  • Some of the laminates for skin application are desired to be applied to the skin for a long time.
  • Such a skin patch laminate has excellent permeability of water vapor released from the skin, and has less discomfort due to the weight and feeling of foreign matter when it is applied, and follows the movement of the skin. Is also desired.
  • an object of an embodiment of the present disclosure is to apply a skin that is applied without feeling uncomfortable, follows the movement of the skin, and has excellent permeability of water vapor released from the skin. ⁇ 0 2020/175681 2 (:171? 2020/008363
  • An object of the present invention is to provide a laminated body for use and a manufacturing method thereof.
  • Laminate for skin application Laminate for skin application.
  • the surface of the first support on the first layer side and the surface of the second support on the second layer side at least _ have a silicone layer or are surface-treated with silicone.
  • Step 8 a coating liquid containing a silicone polymer having a crosslinkable group, a crosslinking agent, and a solvent is applied and dried on the first support to form a first layer.
  • Step 8 a coating liquid containing a silicone polymer having a crosslinkable group, a crosslinking agent, silica particles, and a silicone solvent is applied and dried on the first support to form a first layer.
  • step S is a step of forming the second layer on the first layer.
  • Laminate for skin application according to any one of [9] to [12], in which the first support is continuously conveyed and the process and process are performed by the mouth-to-roll method. Body manufacturing method.
  • Step 1 of attaching a protective film to the surface of the first layer formed in step 8 between step 8 and step _, and the laminated protective film from the surface of the first layer The method for producing a skin patch laminate according to any one of [9] to [13], further comprising a peeling step 82.
  • the surface of the first layer hydrophilically treated in step 83 has a contact angle with 1 ⁇ 1-methyl-2-pyrrolidone of 60° or less, and the skin according to [1 5] Method for manufacturing laminated body for sticking.
  • a skin-adhesive laminate which is affixed without any discomfort, follows the movement of the skin, and has excellent permeability of water vapor released from the skin, and a method for producing the same. be able to.
  • the numerical range indicated by “to” indicates the range including the numerical values before and after “to” as the minimum value and the maximum value, respectively.
  • the amount of each component contained in the composition means the total amount of the plurality of substances, unless otherwise specified, when the composition contains a plurality of substances corresponding to the respective components.
  • the upper limit value or the lower limit value described in a certain numerical range may be replaced with the upper limit value or the lower limit value of another stepwise described numerical range. .. Further, in the numerical ranges described in the present specification, the upper limit value or the lower limit value described in a certain numerical range may be replaced with the values shown in the examples.
  • (meth)acrylic means at least one of acrylic and methacrylic.
  • a skin patch laminate of the present disclosure (hereinafter, also referred to as “laminate of the present disclosure”) has a first layer containing a silicone elastomer, and a second layer that is in contact with the first layer and exhibits adhesiveness. ..
  • the laminate of the first layer and the second layer of the laminate of the present disclosure has a tensile stress at 40% elongation of ⁇ .
  • the total thickness is less than or equal to 101 01. ⁇ 02020/175681 5 ⁇ (: 171? 2020 /008363
  • the laminate of the present disclosure has a tensile stress of 40% elongation of the laminate of the first layer and the second layer. Below, and the total thickness is 1 It is presumed that the following will be applied with no discomfort and will have the effect of following the movement of the skin.
  • the first layer is a layer containing a silicone elastomer, it is presumed that the first layer has an effect of being excellent in permeability of water vapor released from the skin due to its material.
  • None of the laminates described in Japanese Patent Publication No. 3 has a layer containing a silicone elastomer as a layer adjacent to the adhesive layer. Further, in the laminates described in JP-A-2010-04395-O and JP-A-2016-022223, the tensile stress in the laminate of the adhesive layer and the adjacent layer is not examined at all.
  • the tensile stress at 40% elongation of the laminate of the first layer and the second layer is 0. It is the following.
  • the tensile stress at 40% elongation of the laminate is easy to follow the movement of the skin.
  • the following is preferred, and ⁇ .61 ⁇ /1 3 or less is more preferred, ⁇ .
  • the lower limit of tensile stress at 40% elongation of the laminate is, for example, 0.001 IV! 3 .
  • the tensile stress at 10% elongation of the laminated body of the first layer and the second layer is ⁇ . It is preferably not more than 0.21, more preferably not more than 0.13 and even more preferably not more than 0.1 IV! 3.
  • the lower limit of the tensile stress at 10% elongation of the laminate is, for example, 0.001 IV! 3 .
  • the tensile elongation at break of the laminate of the first layer and the second layer is preferably 100% or more, and 150% or more. Is more preferable and 200% or more is further preferable.
  • the upper limit of the tensile elongation at break of the laminate is, for example, 900%.
  • the method for adjusting the tensile stress and the tensile elongation at break of the first layer, the tensile stress and the tensile elongation at break of the second layer are adjusted. And a method of adjusting the film thickness ratio between the first layer and the second layer.
  • the tensile stress and tensile elongation at break of the laminate should be adjusted by adjusting the tensile stress and tensile elongation at break of the first layer in the laminate. It is preferable to control by a method.
  • the tensile stress at 40% elongation and the tensile elongation at break in the laminate are measured as follows.
  • the test piece shall be extended in an environment of 25 ⁇ 2 ° .
  • the tensile stress at 10% elongation is the tensile stress at 10% elongation except that the load (1 ⁇ ) when the test piece is expanded by 10% is added to the above formula (1). It is calculated in the same way as.
  • the total thickness of the laminate of the first layer and the second layer is 1101 or less.
  • Total thickness is 1 The following items make it less likely to feel weight and foreign matter when applied to the skin, so that the product can be applied comfortably.
  • the total thickness of the laminate is: 7 is preferable, 0.0 1 01 01 to ⁇ 0.5 01 01 is more preferable, and ⁇ . Is more preferable, and 0.02 ⁇ 1 111 to ⁇ 0.11 111 is particularly preferable.
  • the lower limit of the total thickness of the laminated body is, for example, from the viewpoint of manufacturing suitability, 0.00 0.001 01.
  • the total thickness of the laminate of the first layer and the second layer is measured as follows.
  • the thickness of the first support and the second support was calculated from the total thickness of this stack.
  • the total thickness of the first and second layers is obtained by subtracting the thickness. Therefore, the thickness of each of the first support and the second support should be measured beforehand with the above-mentioned constant pressure thickness gauge.
  • test pieces of the laminate used for the measurement have the same shape as the test pieces used for the measurement of the tensile stress and the tensile elongation at break, and three pieces are prepared. ⁇ 0 2020/175681 8 ⁇ (: 171? 2020 /008363
  • the center of the test piece is measured 3 times with the above-mentioned constant pressure thickness gauge, and the average value of 3 times is taken as the thickness of the test piece.
  • the same measurement is performed on three test pieces, and the average value of the thickness of the three test pieces is taken as the total thickness of the laminate of the first layer and the second layer.
  • the first support/first layer is used for the measurement.
  • a laminate composed of one layer/protective film may be applied.
  • the thickness of the first layer can be determined by subtracting the thickness of the first support and the protective film from the total thickness of this laminate. Therefore, in addition to the first support, measure the thickness of the protective film alone with the above-mentioned constant pressure thickness measuring device.
  • the laminate composed of the first support/first layer/protective film is, for example, the first support/first layer/protection obtained through step 1 in the method for producing a skin patch laminate described later.
  • a laminate composed of a film may be mentioned.
  • the thickness of the second layer can also be calculated by subtracting the thickness of only the first layer from the total thickness of the first layer and the second layer obtained by the above method.
  • the laminate of the present disclosure has a first layer that includes a silicone elastomer.
  • the first layer may contain silica particles in addition to the silicone elastomer.
  • the first layer may have a single-layer structure or a multi-layer structure. When the first layer has a multi-layer structure, at least one of the layers may contain a silicone elastomer.
  • the respective layers may have different cross-linking densities of the silicone elastomer.
  • the presence or absence of addition of silica particles may be changed in each layer, or the content of silica particles may be different.
  • the silicone elastomer refers to a crosslinked product of a silicone polymer, and is preferably a three-dimensional crosslinked product of a silicone polymer. ⁇ 02020/175681
  • the three-dimensional crosslinked product of the silicone polymer is more preferably a reaction product of a silicone polymer having a crosslinkable group and a crosslinking agent.
  • silicone polymer having a crosslinkable group examples include polydimethylsiloxane, polymethylphenylsiloxane, polymethyldiphenylsiloxane, and the like, which have two or more crosslinkable groups in the molecule. From the viewpoint of actual use and the ease of obtaining a three-dimensional crosslinked product, polydimethylsiloxane having two or more crosslinkable groups in the molecule is preferable, and polydimethylsiloxane having crosslinkable groups at both main chain terminals is particularly preferable. Is preferred.
  • the crosslinkable group contained in the silicone polymer may be a functional group used in reactions such as hydrosilylation, reaction with organic peroxide, deacetic acid, dehydration, dealcoholization, etc., which is known as a crosslinking reaction of silicone polymers. Good. Among them, as the crosslinking reaction of the silicone polymer, hydrosilylation that does not generate a reaction by-product is preferable, and as the crosslinking group, a vinyl group is particularly preferable.
  • silicone polymer having a crosslinkable group polydimethylsiloxane having vinyl groups at both main chain terminals is particularly preferable.
  • the weight average molecular weight of the silicone polymer having a crosslinkable group is not particularly limited, but examples thereof include 800 to 50,000, and preferably 10,000 to 300,000.
  • the silicone polymer having a crosslinkable group may be used alone or in combination of two or more.
  • the weight average molecular weight of the silicone polymer having a crosslinkable group can be measured by gel permeation chromatography (XX). Specifically, 1 ⁇ 11_ ⁇ 81 81 ⁇ ⁇ , 30-8020 (Tosoh Corporation) was used, and the column was D3 3 ⁇ 96 1, 3 Li 6 “1 ⁇ 11 ⁇ /1— 1 ⁇ 1 (Tosoh Corporation, 6.
  • sample concentration is 0.5 mass% and flow rate is 0.9.
  • the sample injection amount can be set to 10 (microliter), the measurement temperature can be set to 40 ° , and a differential refractometer ([3 ⁇ 4]) detector can be used.
  • ⁇ 02020/175681 10 ((171?2020/008363
  • the calibration curve is based on Tosoh Corporation “ ⁇ I ⁇ Standard sample knife 3
  • the cross-linking agent is not particularly limited as long as it has a functional group that reacts with the cross-linking group of the silicone polymer having a cross-linking group, but from the viewpoint of easy control of the cross-linking density, a siloxane compound is used. Preferably.
  • a siloxane compound having two or more hydrosilyl groups in the molecule is preferable.
  • polymethylhydrosiloxane a copolymer of methylhydrosiloxane and dimethylsiloxane, polymethylphenyl is preferable. Examples thereof include copolymers of siloxane or polymethyldiphenylsiloxane and polymethylhydrosiloxane.
  • cross-linking agent a copolymer of methylhydrosiloxane and dimethylsiloxane is particularly preferable.
  • the weight average molecular weight of the siloxane compound that is preferable as the crosslinking agent is not particularly limited, but examples thereof include 500 to 30,000, and preferably 10,000 to 25,000.
  • the weight average molecular weight of the siloxane compound is measured by the same method as the weight average molecular weight of the silicone polymer having a crosslinkable group.
  • the crosslinking agents may be used alone or in combination of two or more.
  • the amount ratio of the silicone polymer having a crosslinkable group and the crosslinking agent may be determined according to the tensile stress and the tensile elongation at break required for the first layer.
  • the silicone elastomer contained in the first layer is ⁇ 0 2020/175681 1 1 ⁇ (: 171? 2020 /008363
  • the presence of the crosslinked structure due to the hydrosilylation reaction can be estimated by confirming the presence or absence of a vinyl group and the presence or absence of a metal catalyst (preferably both) in the first layer.
  • a metal catalyst may be used in the hydrosilylation reaction as described later. Therefore, by confirming the presence or absence of the metal catalyst in the first layer, the existence of a crosslinked structure due to the hydrosilylation reaction in the silicone elastomer is estimated.
  • the presence or absence of the vinyl group can be confirmed by using the nuclear magnetic resonance spectroscopy or the like for the vinyl group remaining in the first layer.
  • Nuclear magnetic resonance spectroscopy can be performed, for example, by Bruker 888 1 ⁇ 100 III 600 is used.
  • the presence or absence of a metal catalyst can be confirmed by analyzing metal elements (platinum, titanium, etc.) by X-ray fluorescence analysis.
  • metal elements platinum, titanium, etc.
  • X-ray fluorescence analysis for example, “R011 type 311 manufactured by Rigaku Corporation” is used.
  • the content of the silicone elastomer (that is, a cross-linked product of the silicone polymer) is 70% by mass to 10% with respect to the total mass of the first layer. 0 mass% is preferable, 75 mass% to 100 mass% is more preferable, and 80 mass% to 100 mass% is further preferable.
  • the content of silicone elastomer _ (that is, a cross-linked product of silicone polymer) is 70% by mass to 93% by mass with respect to the total mass of the first layer. 75% by mass to 93% by mass is more preferable, and 80% by mass to 90% by mass is further preferable.
  • the first layer preferably contains silica particles. ⁇ 0 2020/175681 12 ⁇ (: 171? 2020 /008363
  • the inclusion of silica particles makes it easier to control the tensile stress and tensile fracture elongation of the first layer.
  • the first layer contains silica particles as follows.
  • the presence or absence of silica particles can be directly confirmed by dissolving the first layer and observing the dissolved solution with a transmission electron microscope (Chomi! ⁇ /1).
  • a transmission electron microscope for example, is a JEOL Ltd.'s "1 ⁇ /1-1 2 0 0 ⁇ -Cho 1 ⁇ /1", and the acceleration voltage at the time of measurement is 1 2 0 1 ⁇
  • the solution for the first layer can be prepared by immersing the first layer in a mixed solution of methyl orthoformate, methanolic hydrochloric acid, and toluene, and stirring the solution.
  • the silica particles are not particularly limited, and may be any of fumed silica and colloidal silica, and may be crystalline or amorphous.
  • fumed silica is preferable from the viewpoints of dispersibility in a silicone solvent, dispersibility in a crosslinked product of a silicone polymer, and stability of coating solution viscosity.
  • the shape of silica particles is not particularly limited. However, a spherical shape, a plate shape, a needle shape, a bead shape, or a shape in which two or more kinds of these are combined is included.
  • the silica particles have an average primary particle size of 3 n from the viewpoint of dispersibility in the first layer.
  • the average primary particle size of the silica particles is measured by observing the first layer with a transmission electron microscope (Cho IV!). More specifically, the average primary particle diameter of the silica particles is, when the shape of the silica particles is spherical or substantially spherical with an elliptical cross section, the silica particles dispersed in the first layer are observed by a transmission electron microscope, From the obtained observation photograph, the projected area of 300 or more particles is measured, the equivalent circle diameter is determined from the projected area, and the obtained equivalent circle diameter is taken as the average primary particle diameter of silica particles. If the shape of silica particles is not spherical or nearly spherical, use another method. ⁇ 0 2020/175681 13 ⁇ (: 171? 2020 /008363
  • the average primary particle diameter of silica particles is determined.
  • the content of the silica particles is such that the bow I tensile stress and the tensile elongation at break of the first layer can be easily controlled with respect to the total mass of the first layer. , 7 mass% to 30 mass% is preferable, 7 mass% to 25 mass% is more preferable, and 10 mass% to 20 mass% is further preferable.
  • the first layer may contain other components in addition to the above-mentioned silicone elastomer (that is, a crosslinked product of silicone polymer) and silica particles.
  • Other components include a silicone elastomer (that is, a silicone polymer). (A crosslinked product of mer), and a reaction catalyst and the like used.
  • a coloring agent such as a pigment may be used.
  • the reaction catalyst used when obtaining the silicone elastomer may be any catalyst that contributes to the promotion of the reaction for obtaining the three-dimensional crosslinked product of the silicone polymer.
  • the reaction catalyst is preferably a catalyst for promoting the hydrosilylation reaction.
  • reaction catalyst examples include metal catalysts, and in particular, platinum, titanium, gold, silver and the like are mentioned from the viewpoint of low irritation to the skin.
  • titanium and platinum are preferable as the catalyst from the viewpoint of high reaction promoting efficiency and low skin irritation.
  • platinum catalyst a known platinum catalyst (preferably platinum complex) that contributes to reaction promotion for obtaining a three-dimensional crosslinked product of a silicone polymer can be applied.
  • the thickness of the first layer is from the viewpoint of suppressing a feeling of discomfort such as a feeling of weight during attachment, and ⁇ 0 2020/175681 14 ⁇ (: 171? 2020 /008363
  • the laminate of the present disclosure has a second layer that is in contact with the above-mentioned first layer and exhibits tackiness.
  • the second layer corresponds to the layer attached to the skin, it may be any layer that is adhesive to the skin.
  • adheresiveness refers to a property of stickiness, which is used for temporary adhesion and can be peeled off later.
  • the second layer is preferably a layer containing an adhesive.
  • the pressure-sensitive adhesive is not particularly limited, and known pressure-sensitive adhesives can be used. Specific examples of the pressure sensitive adhesive include silicone pressure sensitive adhesive, acrylic pressure sensitive adhesive, rubber pressure sensitive adhesive and urethane pressure sensitive adhesive.
  • a silicone-based pressure-sensitive adhesive is preferable from the viewpoint of low irritation to the skin and from the viewpoint of adhesion to the first layer.
  • the silicone-based pressure-sensitive adhesive in the present disclosure means a pressure-sensitive adhesive that uses a silicone polymer as a base polymer (a main component among polymer components, that is, a component that accounts for 50% by mass or more of the entire polymer component).
  • the silicone adhesive is not particularly limited, and known silicone adhesives can be used.
  • silicone-based pressure-sensitive adhesive examples include an addition reaction-type silicone-based pressure-sensitive adhesive, a peroxide-curable silicone-based pressure-sensitive adhesive, and a condensation-type silicone-based pressure-sensitive adhesive. Above all, an addition reaction type silicone-based pressure-sensitive adhesive by hydrosilylation is preferable from the viewpoint that reaction by-products are not generated.
  • an addition reaction type silicone containing the same silicone polymer having a crosslinkable group and the crosslinking agent as the first layer ⁇ 0 2020/175681 15 ⁇ (: 171? 2020 /008363
  • the silicone-based pressure-sensitive adhesive preferably contains, for example, polydimethylsiloxane having vinyl groups at both ends of the main chain, and a copolymer of methylhydrosiloxane and dimethylsiloxan.
  • the silicone-based pressure-sensitive adhesive may contain a reaction catalyst.
  • silicone-based pressure-sensitive adhesive may optionally contain various additives contained in known silicone-based pressure-sensitive adhesives.
  • the acrylic pressure-sensitive adhesive in the present disclosure means a pressure-sensitive adhesive using an acrylic polymer as a base polymer.
  • the acrylic pressure-sensitive adhesive is not particularly limited, and known acrylic pressure-sensitive adhesives can be used.
  • acrylic polymer contained in the acrylic pressure-sensitive adhesive include a homopolymer of an acrylic acid ester compound or a copolymer of an acrylic acid ester compound and another monomer.
  • acrylic acid ester compounds include methyl (meth)acrylate, ethyl (meth)acrylate, butyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, hydroxyethyl methacrylate, hydroxypropyl methacrylate, dimethyl.
  • Aminoethyl methacrylate, glycidyl methacrylate and the like can be mentioned.
  • examples of other monomers include vinyl acetate, (meth)acrylonitrile, (meth)acrylic amide, styrene, methacrylic acid, acrylic acid, itaconic acid, methylol acrylic amide, maleic anhydride and the like.
  • the acrylic polymer may have a crosslinked structure.
  • the acrylic pressure-sensitive adhesive may contain a tackifier in addition to the acrylic polymer from the viewpoint of enhancing the tackiness.
  • tackifiers include rosin-based tackifier resins, terpene-based tackifier resins, hydrocarbon-based tackifier resins, epoxy-based tackifier resins, and polyamides. ⁇ 0 2020/175681 16 ⁇ (: 171? 2020 /008363
  • tackifying resin examples include an elastomer-based tackifying resin, an elastomer-based tackifying resin, a phenol-based tackifying resin, and a ketone-based tackifying resin.
  • the acrylate-based pressure-sensitive adhesive may contain, in addition to the acrylate polymer and the tackifier, various additives contained in known acrylic-based pressure-sensitive adhesives, if necessary.
  • the rubber-based pressure-sensitive adhesive in the present disclosure means a pressure-sensitive adhesive having rubber as a base polymer.
  • the rubber is not particularly limited, and may be natural rubber (including modified natural rubber) or synthetic rubber.
  • a type or a type block copolymer is a thermoplastic block, and a type is a rubber block.
  • Styrene-isoprene styrene copolymer (3 1 3), styrene-butadiene Examples thereof include styrene copolymers (363) and the like.
  • the rubber may be a combination of natural rubber and synthetic rubber.
  • the rubber-based pressure-sensitive adhesive may contain a tackifier in addition to the rubber from the viewpoint of enhancing the tackiness.
  • tackifier examples include various tackifier resins used for acrylate-based tackifiers.
  • the rubber-based pressure-sensitive adhesive may contain, in addition to the rubber and the tackifier, various additives contained in known rubber-based pressure-sensitive adhesives, if necessary.
  • the second layer may contain other components in addition to the adhesive. Other components may be appropriately determined depending on the use of the skin patch laminate.
  • the second layer preferably contains a drug and an additive for retaining and releasing the drug.
  • the drug a known drug applicable to transdermal preparations is used.
  • an additive for holding and releasing the drug from the viewpoint of actual use, for example, lactic acid, glycolic acid, stearic acid, oleic acid, isopropyl myristate,! _ _Menthol, ethanol, propylene glycol, etc.
  • the thickness of the second layer is 5 to 3 from the viewpoint of exhibiting adhesion to the skin.
  • the laminate of the present disclosure includes a first support member that contacts the surface of the first layer opposite to the surface that contacts the second layer, and a first support member that contacts the surface of the second layer opposite to the surface that contacts the first layer. Two supports may be included.
  • the first support and the second support are temporary supports that are peeled off when attached to the skin.
  • the first support and the second support are not particularly limited, and a resin film is preferably used.
  • first support and the second support may be the same or different.
  • the resin film examples include resin films such as polyester (for example, polyethylene terephthalate (polyester), polyethylene naphthalate, polypropylene terephthalate, etc.), polyurethane, silicone, polyolefin (for example, polyethylene, polypropylene, etc.), polystyrene, etc.
  • resin films such as polyester (for example, polyethylene terephthalate (polyester), polyethylene naphthalate, polypropylene terephthalate, etc.), polyurethane, silicone, polyolefin (for example, polyethylene, polypropylene, etc.), polystyrene, etc.
  • polyester for example, polyethylene terephthalate (polyester), polyethylene naphthalate, polypropylene terephthalate, etc.
  • polyurethane silicone
  • polyolefin for example, polyethylene, polypropylene, etc.
  • polystyrene etc.
  • polyethylene terephthalate (Mending) is preferable
  • the thickness of the first support and the second support is not particularly limited, but from the viewpoint of excellent handleability when applied to the mouth-to-roll method and the ease of peeling, 100 ! ⁇ 100 is preferred, 2011 ⁇ 100 is more preferred ⁇ 0 2020/175681 18 ⁇ (: 171? 2020 /008363
  • the first support and the second support are peeled off at the time of application to the skin, and therefore, between the first support and the first layer, and between the second support and the second layer. It is preferable to have a peeling property between them.
  • At least one of the first support side of the first support and the second support side of the second support has a silicone layer or is surface-treated with silicone, if necessary. ..
  • the silicone layer may be a layer containing a silicone polymer, and is preferably a layer containing a fluorosilicone polymer having a substituent containing a fluorine atom or a fluorine atom in the molecule (hereinafter, also referred to as a fluorosilicone layer). ..
  • a fluorosilicone layer By adjusting the amount of fluorine atoms in the fluorosilicone polymer, the peelability from the first layer and the second layer can be controlled.
  • the surface treatment with silicone includes, for example, surface treatment using liquid phase film formation using a solution coating/drying method.
  • surface treatment with a fluorine-containing compound may be used, for example.
  • surface treatment using vapor phase film formation such as sputtering or vapor deposition is applied.
  • first support and the second support commercially available products may be used.
  • commercially available products include a release film (for example, a fluorosilicone release film, etc.) having a silicone layer manufactured by Fujiko Co., Ltd. on one side or both sides.
  • the skin patch laminate of the present disclosure is preferably produced by the following method (that is, the method for producing the skin patch laminate of the present disclosure).
  • the method for producing a skin patch laminate of the present disclosure includes a step 8 of forming a first layer containing a silicone elastomer, and a step of forming a second layer having adhesiveness.
  • the tensile stress at 40% elongation of the laminate of the first layer and the second layer is ⁇ . ⁇ 02020/175681 19
  • the following is a method for producing a laminate for skin application (hereinafter, also referred to as a method for producing a laminate).
  • a first layer containing a silicone elastomer is formed.
  • the method for forming the first layer is not limited, but the following steps are preferable.
  • a coating liquid (hereinafter, also referred to as coating liquid!-1) containing a silicone polymer having a crosslinkable group, a crosslinking agent, and a solvent is applied onto the first support and dried to form a first coating.
  • coating liquid!-1 a coating liquid containing a silicone polymer having a crosslinkable group, a crosslinking agent, and a solvent is applied onto the first support and dried to form a first coating.
  • the eighth step of forming a layer is preferable.
  • Step 8 is to coat and dry a coating solution (hereinafter also referred to as coating solution 1-2) containing a silicone polymer having a crosslinkable group, a crosslinking agent, silica particles, and a silicone solvent on the first support. Then, the step of forming the first layer is preferable.
  • a coating solution hereinafter also referred to as coating solution 1-2
  • the step is formed by applying and drying the coating liquid !_ 1 or !_ 2 on the first support.
  • the first support that is continuously conveyed is used and that the steps and the steps described below are performed by a mouth-to-roll method.
  • silicone polymer having a crosslinkable group, the crosslinker, and the silica particles contained in 1 and 1_2 include the components described in the section of the first layer, and the preferred embodiments are also the same. ..
  • the solvent contained in 1 and !_ 2 is preferably a good solvent for a silicone polymer having a crosslinkable group.
  • the good solvent for the silicone polymer having a crosslinkable group include silicone solvents, ethyl acetate, heptane, tetrahydrofuran, methyl ethyl ketone, and the like.
  • the solvents contained in the coating liquids 1_1 and 1-2 may be used alone or in combination of two or more. Above all, a silicone-based solvent is preferable as the solvent contained in the coating liquids !_ 1 and !_ 2. ⁇ 0 2020/175681 20 ⁇ (: 171? 2020 /008363
  • Coating liquid! -1 and the silicone solvent contained in the coating liquid 1_2 are preferably cyclic siloxanes such as hexamethylcyclotrisiloxane, octamethylcyclotetrasiloxane, and decamethylcyclotetrasiloxane (also referred to as cyclopentasiloxane).
  • Coating liquid !_ 1 and coating liquid !_ 2 may each contain the other components described in the section of the first layer.
  • the coating liquid 1-1 and the coating liquid !_2 may contain a reaction retarder, a reaction inhibitor, etc. used in the reaction for obtaining the silicone elastomer.
  • the reaction retarder or reaction inhibitor is preferably a component that does not easily remain in the first layer, and is preferably a volatile (for example, boiling point is 100 ° C. or less) compound. It is more preferable that the compound has a boiling point lower than that of the solvent (eg, silicone-based solvent such as cyclic siloxane) contained in _ 1 and the coating liquid !_ 2.
  • the reaction retarder or reaction inhibitor include, for example, acetylene alcohols (eg, 2-methyl-3-butyne-2-yl), cyclic siloxanes (eg, tetravinyltetramethylcyclotetrasiloxane), etc. Is mentioned.
  • the solid content (total amount of components excluding the solvent) in the coating liquid !_ 1 and the coating liquid !_ 2 depends on the ease of applying the coating liquid, the ease of feeding and filtering the coating liquid, and the like. It may be determined according to the conditions, preferably 10% by mass to 70% by mass, more preferably 15% by mass to 65% by mass, further preferably 20% by mass to 50% by mass.
  • Examples of the first support used in step 8 include the above-mentioned first support, and the preferred embodiments are also the same.
  • the first support used in step 8 preferably has a silicone layer on the surface on the first layer side from the viewpoint of enhancing the releasability from the first layer.
  • Coating liquid !_ 1 or coating liquid! As the coating method of -2, a known coating method can be applied. ⁇ 0 2020/175681 21 ⁇ (: 171? 2020 /008363
  • Specific coating methods include force-ten coating method, dip coating method, spin coating method, print coating method, spray coating method, slot coating method, mouth coating method, slide coating method, blade coating method. Method, gravure coating method, wire bar method and the like.
  • the slot coating method is preferable as the coating method when the step 8 is performed by the mouth toe roll method using the first support which is continuously conveyed.
  • drying method examples include a method using an oven, a warm air blower, an infrared ray (see [3 ⁇ 4] heater), and the like.
  • warm air may be applied from the surface of the first support opposite to the surface coated with the coating liquid.
  • the drying conditions e.g., in the range of 7 0 ° ⁇ ⁇ 1 1 0 ° ⁇ , between 1 0 minutes to 3 0 minutes is preferred.
  • the first layer after drying may be heated to remove the reaction delay agent, reaction inhibitor, etc. contained in the coating liquid !_ 1 and the coating liquid !_2. .. Heating conditions during this heating may, for example, in the range of 7 0 ° ⁇ ⁇ 1 5 0 ° ⁇ , preferably 3 0 minutes to 9 0 minutes.
  • the second layer having adhesiveness is formed.
  • the process step may be, for example, a step of forming the second layer on the second support described later, or a step of forming the second layer on the first layer formed in step 8. Good.
  • the process step is a process of forming the second layer on the second support
  • the first layer is formed on the formed second layer in step 8
  • the laminated body of the present disclosure is manufactured. Good.
  • the process step is a process of forming the second layer on the second support
  • the second layer formed and the first layer formed on the first support in step 8 are attached. match ⁇ 0 2020/175681 22 ⁇ (: 171? 2020 /008363
  • the laminated body of the present disclosure may be manufactured.
  • the process step is a step of forming the second layer on the first layer formed in step 8.
  • the process step is preferably a process of forming a second layer by applying a coating liquid containing an adhesive (hereinafter, also referred to as coating liquid 1-3) on the first layer and drying the coating liquid. ..
  • a coating liquid containing an adhesive hereinafter, also referred to as coating liquid 1-3
  • Examples of the adhesive contained in the coating liquids 1_3 include the adhesives described in the section of the second layer, and the preferred embodiments are also the same.
  • the coating liquids 1_3 preferably contain a solvent together with the adhesive.
  • the solvent contained in the coating liquids 1_3 is preferably a good solvent for the base polymer in the adhesive.
  • the adhesive contained in 1_3 is a silicone-based adhesive
  • silicone-based solvents include the silicone-based solvents contained in coating liquid !-1 and coating liquid !_2.
  • the solid content (total amount of components excluding the solvent) in the coating liquid 1-3 is determined according to the ease of applying the coating liquid, the ease with which the coating liquid is delivered and filtered. Of course, 10 mass% to 65 mass% is preferable, 15 mass% to 60 mass% is more preferable, and 25 mass% to 55 mass% is further preferable.
  • Examples of the coating method and the drying method used in the process step include the coating method and the drying method in the step, and preferred embodiments are also the same.
  • the first support to be conveyed be used to carry out the steps and steps in a mouth-to-roll method.
  • step 8 in order to protect the first layer, the following steps should be performed between step 8 and step ⁇ 0 2020/175681 23 ⁇ (: 171? 2020 /008363
  • step 81 and step 82 It is preferable to carry out step 81 and step 82.
  • the first support having the first layer may be wound after the process 8 but before the process. is there.
  • the first layer may be damaged. Therefore, it is preferable to protect the surface of the first layer by performing the following steps 81 and 82 between step 8 and step.
  • step 81 a protective film is attached to the surface of the first layer formed in step 8.
  • the protective film it is preferable that at least the surface in contact with the first layer has releasability from the first layer.
  • the protective film examples include a Mitsuhachi (ethylene-vinyl acetate copolymer resin) film (commercially available products include, for example, 803 series of Sanae Kaken Co., Ltd. 80 series), polyolefin film ( Examples of commercially available products include surface protective films of Toray Industries, Inc., Tretec (registered trademark) series, and the like.
  • Mitsuhachi ethylene-vinyl acetate copolymer resin
  • commercially available products include, for example, 803 series of Sanae Kaken Co., Ltd. 80 series
  • polyolefin film examples include surface protective films of Toray Industries, Inc., Tretec (registered trademark) series, and the like.
  • a known film laminating method such as a mouth laminating method can be applied.
  • step 82 the protective film attached in step 81 is peeled from the surface of the first layer.
  • Examples of the hydrophilic treatment for the surface of the first layer performed in step 83 include corona treatment and plasma treatment. Particularly, from the viewpoint of productivity and the viewpoint of equipment maintenance, corona treatment is preferable.
  • the corona treatment device used for corona treatment is not particularly limited, for example, vetaphone, In addition to the corona treatment equipment that can be processed by the mouth-to-roll method such as manufactured by the company, there is a Tatsumi (3 _ 4) manufactured by Kasuga Electric Co., Ltd.
  • the conditions for the hydrophilization treatment may be appropriately determined, for example, so that the contact angle is as shown below.
  • the surface of the first layer hydrophilized in step 83 was 1 ⁇ 1-methyl-2-pyrrolidone (hereinafter, Also referred to as a contact angle) is preferably 60 degrees or less, and more preferably 50 degrees or less.
  • a contact angle meter for example, mouth 1 ⁇ /1 ⁇ _7101 of Kyowa Surface Science Co., Ltd.
  • the contact angle shall be measured at 25°°.
  • step ⁇ 3 of laminating the second support on the second layer after the second layer is formed in the step it is preferable to have a step ⁇ 3 of laminating the second support on the second layer after the second layer is formed in the step.
  • Examples of the second support used in the step ⁇ include the above-mentioned second support, and the preferred embodiments are also the same.
  • the second support used in the step ⁇ has a silicone layer on the surface on the second layer side from the viewpoint of enhancing the releasability from the second layer.
  • the laminate of the present disclosure can be manufactured as described above.
  • the application of the laminate of the present disclosure is not particularly limited as long as it is applied to the skin of the application target person. ⁇ 0 2020/175681 25 ⁇ (: 171? 2020 /008363
  • the laminate of the present disclosure is applied without feeling uncomfortable, follows the movement of the skin, and has excellent permeability of water vapor released from the skin, it is a use for a long time of application of the present disclosure. The effect of the laminated body is easily exhibited.
  • the laminate of the present disclosure is preferably used for a living body monitoring device, a display element, a wound dressing material, a transdermal preparation, or a cosmetic product.
  • a biological monitoring device it can be attached to the skin of the target person to obtain biological information of the target person (for example, skin temperature, blood pressure, blood oxygen concentration, heart rate, pulse rate, UV dose, activity level, heart rate, heart rate). Examples include electric monitors, wearable devices that measure sweat ( ⁇ ! ⁇ !, etc.).
  • the layered product of the present disclosure can be applied to a part to be attached to the skin that is a part of the biological monitoring device.
  • the display element has, for example, a display function (for example, an organic semiconductor 1_display, etc.), and by sticking it on the skin of the person to whom it is applied, by sticking it on the skin of the person to whom it is applied, Examples include wearable devices that display information (the same as above) and other information (for example, mobile terminal information).
  • the laminated body of the present disclosure can be applied to a part to be attached to the skin which is a part of the display element.
  • Wound dressings also called dressings, are laminates that are used to cover skin wounds, burns, etc. by applying them to the skin of the person to whom they are applied.
  • the laminate of the present disclosure may be used as a wound dressing itself, may be applied to the joining portion to the skin is a _ part of the wound dressing.
  • the transdermal preparation is a laminate used for percutaneously absorbing the drug contained in the transdermal preparation by applying it to the skin of the application subject.
  • the layered product of the present disclosure preferably contains a drug in the second layer and is used as a transdermal preparation itself.
  • the layered product of the present disclosure is applied to the skin of an application target, for example, as a cosmetic to beautify the skin. You may use.
  • the laminate of the present disclosure may be used as a cosmetic for the purpose of concealing wounds, spots, tattoos, etc. on the skin, or as a cosmetic for the purpose of filling or extending wrinkles on the skin. Good. ⁇ How to use the laminate>
  • the layered product of the present disclosure is used by being attached to the skin of the person to whom it is applied, but the place of attachment is not particularly limited.
  • the laminate of the present disclosure may be attached, for example, a nail or the like, or may be attached across both the skin and the nail, as long as the adhesiveness can be exhibited.
  • the laminate of the present disclosure can be applied to a joint site such as a knee, an elbow, or a finger, since it can be applied without a feeling of strangeness and follows the movement of the skin.
  • the application time may be, for example, 48 hours or more.
  • the vial silica particles Alfa Corp., Si I icon (IV) oxide , amorphous fume d, surface treated, the specific surface area by the B ET method: 205 m 2 / g ⁇ 245 m 2 / g, CAS 7631-86-9 ), cyclopentasiloxane (manufactured by Shin-Etsu Chemical Co., Ltd., K F-995) loxane), vinyl terminated, weight average molecular weight ⁇ 25,000, viscosity 850-1 ,150 c St) and stir until the powder of silica particles dissolves.
  • a metal catalyst (abbreviated as Pt catalyst, platinum ( ⁇ ) — 1,3-divinyl-1,1,1,3,3-tetramethyldisiloxane complex solution ( Aldrich)) is added in an amount of 500 ppm with respect to the total mass of the coating solution, and the mixture is stirred for 30 minutes.
  • Pt catalyst platinum ( ⁇ ) — 1,3-divinyl-1,1,1,3,3-tetramethyldisiloxane complex solution ( Aldrich)
  • H — PDMS methylhydrosiloxane and dimethylsiloxane
  • Polv dimethylsi loxane-co-methy [hydros i loxane), tr imethy isiily terminated, number average molecular weight ⁇ 13,000, methy Ihydrosi loxane 3 ⁇ 4mol
  • number average molecular weight ⁇ 13,000, methy Ihydrosi loxane 3 ⁇ 4mol was added and stirred to obtain a coating solution for forming the first layer.
  • the coating liquid for forming the first layer was diluted with cyclopentasiloxane so that the solid content of silica particles, V-P DMS, and H-P D MS was 65% by mass.
  • a release film having a fluorosilicone layer on the surface of the PET film (manufactured by Fujiko, model number K1, thickness 50 Mm) was prepared.
  • the coating liquid for forming the first layer was applied onto the fluorosilicone layer of the first support by adjusting the thickness so that the coating amount was appropriate to obtain a desired film thickness.
  • the coating solution was applied 2 minutes after the copolymer of methylhydrosiloxane and dimethylsiloxane was added.
  • the cyclopentasiloxane was removed by performing a drying treatment for 1 hour in a blast dryer at 90°C to form a first layer.
  • the surface of the first layer was subjected to corona treatment to make the surface hydrophilic.
  • corona treatment device TEC-4AX manufactured by Kasuga Electric Co., Ltd. was used. Corona treatment conditions were 0.74 J/cm 2 .
  • the contact angle between the surface of the first layer and NMP after corona treatment was 60 degrees or less in all cases.
  • the contact angle between the surface of the first layer after corona treatment and NMP was measured by the method described above.
  • a silicone adhesive (Bio PSA 7 -4202, manufactured by Dow Corning) was diluted with ethyl acetate to prepare a coating solution for forming the second layer.
  • a second layer was formed by removing ethyl acetate by drying in a machine for 1 hour.
  • a release film having a fluorosilicone layer on the surface of the Mending film (manufactured by Fujico, model number [ ⁇ 1, thickness 50) was attached to obtain a laminate.
  • Example 14 A laminated body of Example 14 was obtained in the same manner as in Examples 1 to 13 except that the formation of the second layer was changed as follows.
  • Styrene-isoprene-styrene block copolymer a thermoplastic elastomer 3 I 3500 2 (trade name)) 50 parts by mass, and Alcon (registered trademark) which is an alicyclic saturated hydrocarbon resin as an adhesiveness-imparting agent.
  • the total amount of the thermoplastic elastomer and the tackiness-imparting agent is 15% by mass with respect to the total mass of the rubber-based pressure-sensitive adhesive, and is dissolved in the above mixed solvent. , Sufficiently stirred.
  • the coating liquid for forming the second layer is applied on the first layer by adjusting the thickness so as to obtain an appropriate coating amount to obtain a desired film thickness, and then applied by a blast dryer at 90° ⁇ .
  • the above mixed solvent was removed by drying for 1 hour to form the second layer.
  • Example 15 a laminate of Example 15 was obtained.
  • the coating liquid for forming the second layer is applied on the first layer by adjusting the thickness so as to obtain an appropriate coating amount to obtain a desired film thickness, and then in a 90 ° blast dryer. Ethyl acetate was removed by drying for 1 hour to form a second layer.
  • Tegaderm registered trademark, 3M Japan KK, 1621, 1 0001X 1 20111 was used.
  • the numerical value shown in the column of “total thickness of the first layer and the second layer” is the thickness after peeling the release film from Tegaderm in Comparative Example 1, and in Comparative Example 2, It is the thickness of I 808.
  • the stress, the tensile stress at 40% elongation, and the tensile elongation at break were measured by the methods described above.
  • test piece was cut out so that the distance between them was 40, and the tensile stress at 40% elongation and the tensile elongation at break were measured by the method described above.
  • Comparative Example 1 Cut the laminated body in each example into 2 0 01 01 X 4 00! On the back of the right hand of 3 testers, then peel off the 1st support and the 2nd support, and the 1st layer and the 2nd layer. Was laminated.
  • Comparative Example 1 with regard to Tegaderm, the release film attached to the adhesive layer was removed to obtain 2 0 ⁇ 1 01 X 4 It was cut into pieces and attached to the backs of the right hands of the three testers.
  • Comparative Example 2 is ⁇ ⁇ 8_ It sticked out and stuck to the back of the right hand of the three testers.
  • Comparative Example 2 is ⁇ ⁇ 8_ It sticked out and stuck to the back of the right hand of the three testers.
  • Three testers evaluated the weight and the feeling of foreign matter (immediately, the feeling of foreign matter on the skin) at the location where the laminate was applied, according to the following three grades. The evaluation points of the three testers were averaged, and this was taken as the evaluation result of the feeling of foreign matter.
  • At least one of the weight and the feeling of foreign matter is not felt at all: 5 points
  • the laminated body in each example was cut into 2 0 01 01 X 400 !!! on the inner side of the upper arms of the three testers, and then the first support and the second support were peeled off, and the first layer and the second support were separated. A laminate of layers was applied.
  • Comparative Example 1 with regard to Tegaderm, the release film attached to the adhesive layer was removed to obtain 2 0 ⁇ 1 01 X 4 It was cut out and attached to the inside of the upper arms of the three testers.
  • Comparative Example 2 is ⁇ ⁇ 81 It sticked out and stuck to the inside of the upper arms of the three testers.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Laminated Bodies (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

One embodiment of the present invention provides: a layered body for skin adhesion, which has a first layer containing a silicone elastomer and a second layer that contacts the first layer and is adhesive, and in which the layered product of the first layer and the second layer has a tensile stress at 40% elongation of 0.8 MPa or less and a total thickness of 1 mm or less; and a method for producing the layered body for skin adhesion.

Description

\¥0 2020/175681 1 卩(:17 2020 /008363 明 細 書 \¥0 2020/175681 1 卩 (: 17 2020/008363 Clarification

発明の名称 : 皮膚貼付け用積層体及びその製造方法 Title of invention: Laminate for skin application and method for producing the same

技術分野 Technical field

[0001 ] 本開示は、 皮膚貼付け用積層体及びその製造方法に関する。 [0001] The present disclosure relates to a laminate for skin application and a method for producing the same.

背景技術 Background technology

[0002] 皮膚貼付け用積層体としては、 例えば、 創傷被覆材、 経皮製剤等が挙げら れ、 その用途は様々である。 [0002] Examples of the skin-adhesive laminate include wound dressings and transdermal preparations, which have various uses.

例えば、 特開 2 0 1 8 - 0 4 3 9 5 0号公報には、 カルボン酸エステルを 含有し、 生体に貼付するための感圧接着剤層と、 感圧接着剤層の厚み方向一 方側に配置され、 感圧接着剤層を支持する基材層と、 感圧接着剤層および前 記基材層の間に介在されるバリア層とを備え、 カルボン酸エステルの 3 値 との差の絶対値

Figure imgf000002_0001
生体貼付用積層 体が開示されている。 For example, in Japanese Patent Laid-Open Publication No. 20 18-0 4 395 0, a pressure-sensitive adhesive layer containing a carboxylic acid ester for sticking to a living body and one of the pressure-sensitive adhesive layers in the thickness direction is used. A base layer disposed on the side and supporting the pressure-sensitive adhesive layer, and a barrier layer interposed between the pressure-sensitive adhesive layer and the base layer, and the difference from the three values of the carboxylic acid ester. Absolute value of
Figure imgf000002_0001
A laminated body for sticking to a living body is disclosed.

[0003] 特開 2 0 1 6— 0 2 2 2 2 3号公報には、 フィルム基材と、 フィルム基材 の底面の第一粘着層と、 フィルム基材の上面の第二粘着層とからなり、 これ ら三層を貫通する貫通孔を有する保護フィルム部材と、 この保護フィルム部 材の第一粘着層と第二粘着層それぞれに貼付している第一剥離ライナーと第 二剥離ライナーとからなる医療用保護フィルム材料が開示されている。 [0003] In Japanese Patent Laid-Open No. 2106-10 2 2 2 23, there is described a film base material, a first adhesive layer on the bottom surface of the film base material, and a second adhesive layer on the upper surface of the film base material. And a first release liner and a second release liner attached to each of the first adhesive layer and the second adhesive layer of the protective film member. The following medical protective film material is disclosed.

発明の概要 Summary of the invention

発明が解決しようとする課題 Problems to be Solved by the Invention

[0004] 皮膚貼付け用積層体には、 長時間、 皮膚へ貼付けることが望まれるものが ある。 このような皮膚貼付け用積層体には、 皮膚から放出される水蒸気の透 過性に優れることに加え、 貼付けているときの重さ及び異物感による違和感 が少なく、 皮膚の動きに対して追従することも望まれている。 [0004] Some of the laminates for skin application are desired to be applied to the skin for a long time. Such a skin patch laminate has excellent permeability of water vapor released from the skin, and has less discomfort due to the weight and feeling of foreign matter when it is applied, and follows the movement of the skin. Is also desired.

[0005] そこで、 本開示の一実施形態の課題は、 違和感なく貼付けられ、 皮膚の動 きに追従し、 且つ、 皮膚から放出される水蒸気の透過性に優れる皮膚貼付け \¥0 2020/175681 2 卩(:171? 2020 /008363 [0005] Therefore, an object of an embodiment of the present disclosure is to apply a skin that is applied without feeling uncomfortable, follows the movement of the skin, and has excellent permeability of water vapor released from the skin. \¥0 2020/175681 2 (:171? 2020/008363

用積層体及びその製造方法を提供することにある。 An object of the present invention is to provide a laminated body for use and a manufacturing method thereof.

課題を解決するための手段 Means for solving the problem

[0006] 本開示は、 以下の実施形態を含む。 [0006] The present disclosure includes the following embodiments.

[1] シリコーンエラストマーを含む第 1層と、 第 1層と接触し且つ粘着 性を示す第 2層と、 を有し、 [1] A first layer containing a silicone elastomer, and a second layer in contact with the first layer and exhibiting adhesiveness,

Figure imgf000003_0001
Figure imgf000003_0001

下であり、 且つ、 総厚みが 1 111 111以下である、 And the total thickness is 1 111 111 or less,

皮膚貼付け用積層体。 Laminate for skin application.

[0007] [2] 第 1層と第 2層との積層物の引張破断伸度が 1 0 0 %以上である、 [0007] [2] The tensile breaking elongation of the laminate of the first layer and the second layer is 100% or more,

[ 1] に記載の皮膚貼付け用積層体。 The laminate for skin application according to [1].

[3] 第 1層がシリカ粒子を含む、 [1] 又は [2] に記載の皮膚貼付け 用積層体。 [3] The laminate for skin application according to [1] or [2], wherein the first layer contains silica particles.

[4] シリカ粒子の含有量が第 1層の全質量に対して 7質量%〜 3 0質量 %である、 [3] に記載の皮膚貼付け用積層体。 [4] The laminate for skin patch according to [3], wherein the content of the silica particles is 7% by mass to 30% by mass with respect to the total mass of the first layer.

[5] シリコーンエラストマーがヒドロシリル化反応による架橋構造を有 する、 [1] 〜 [4] のいずれか 1 に記載の皮膚貼付け用積層体。 [5] The skin patch laminate according to any one of [1] to [4], wherein the silicone elastomer has a crosslinked structure by a hydrosilylation reaction.

[0008] [6] 第 1層の第 2層と接する面とは反対の面側に接する第 1支持体と、 第 2層の第 1層と接する面とは反対の面側に接する第 2支持体と、 を更に有 する、 [1] 〜 [5] のいずれか 1 に記載の皮膚貼付け用積層体。 [0008] [6] The first support member, which is in contact with the surface of the first layer opposite to the surface in contact with the second layer, and the second member, which is in contact with the surface of the second layer opposite to the surface in contact with the first layer. A laminate for skin application according to any one of [1] to [5], further comprising a support.

[7] 第 1支持体の第 1層側の面及び第 2支持体の第 2層側の面の少なく とも _方がシリコーン層を有する又はシリコーンにより表面処理されている 、 [6] に記載の皮膚貼付け用積層体。 [7] The surface of the first support on the first layer side and the surface of the second support on the second layer side at least _ have a silicone layer or are surface-treated with silicone. [6] A laminate for skin application.

[8] 生体モニタリングデバイス、 表示素子、 創傷被覆材、 経皮製剤、 又 は化粧品に用いる、 [1] 〜 [7] のいずれか 1 に記載の皮膚貼付け用積層 体。 [8] The laminate for skin application according to any one of [1] to [7], which is used for a biological monitoring device, a display element, a wound dressing material, a transdermal preparation, or a cosmetic product.

[0009] [9] シリコーンエラストマーを含む第 1層を形成する工程八と、 [0009] [9] Step 8 of forming a first layer containing a silicone elastomer,

粘着性を有する第 2層を形成する工程巳と、 A step of forming a second layer having adhesiveness,

を有し、 \¥0 2020/175681 3 卩(:17 2020 /008363 Have \¥0 2020/175681 3 卩(: 17 2020/008363

第 1層と第 2層との積層物の 4 0 %伸長時の引張応力が〇. 8 1\/1 8以下 であり、 且つ、 総厚みが 1 以下である、 皮膚貼付け用積層体の製造方法 Manufacture of a laminate for skin application, in which the tensile stress at 40% elongation of the laminate of the first layer and the second layer is not more than 0.81\/18 and the total thickness is not more than 1 Method

[0010] [1 0] 工程八が、 第 1支持体上に、 架橋性基を有するシリコーンポリマ 一、 架橋剤、 及び溶剤を含む塗布液を塗布及び乾燥させて、 第 1層を形成す る工程である、 [ 9] に記載の皮膚貼付け用積層体の製造方法。 [0010] [10] In Step 8, a coating liquid containing a silicone polymer having a crosslinkable group, a crosslinking agent, and a solvent is applied and dried on the first support to form a first layer. The method for producing the laminate for skin application according to [9], which is a step.

[1 1] 工程八が、 第 1支持体上に、 架橋性基を有するシリコーンポリマ 一、 架橋剤、 シリカ粒子、 及びシリコーン系溶剤を含む塗布液を塗布及び乾 燥させて、 第 1層を形成する工程である、 [9] に記載の皮膚貼付け用積層 体の製造方法。 [11] In Step 8, a coating liquid containing a silicone polymer having a crosslinkable group, a crosslinking agent, silica particles, and a silicone solvent is applied and dried on the first support to form a first layer. The method for producing a laminate for skin application according to [9], which is a step of forming.

[1 2] 工程巳が、 第 1層上に第 2層を形成する工程である、 [9] 〜 [ 1 1] のいずれか 1 に記載の皮膚貼付け用積層体の製造方法。 [12] The method for producing a skin patch laminate according to any one of [9] to [11], wherein the step S is a step of forming the second layer on the first layer.

[1 3] 連続搬送される第 1支持体を用い、 口ールトゥロール方式にてエ 程八及び工程巳が行われる、 [9] 〜 [1 2] のいずれか 1 に記載の皮膚貼 付け用積層体の製造方法。 [13] Laminate for skin application according to any one of [9] to [12], in which the first support is continuously conveyed and the process and process are performed by the mouth-to-roll method. Body manufacturing method.

[1 4] 工程八と工程巳との間に、 工程八にて形成された第 1層の表面に 保護フィルムを貼り合わせる工程 1、 及び、 貼り合された保護フィルムを 第 1層の表面から剥離する工程八 2と、 を更に含む、 [9] 〜 [1 3] のい ずれか 1 に記載の皮膚貼付け用積層体の製造方法。 [1 4] Step 1 of attaching a protective film to the surface of the first layer formed in step 8 between step 8 and step _, and the laminated protective film from the surface of the first layer The method for producing a skin patch laminate according to any one of [9] to [13], further comprising a peeling step 82.

[001 1] [1 5] 工程八と工程巳との間に、 工程八にて形成された第 1層の表面を 親水化処理する工程八 3を更に含む、 [9] 〜 [1 4] のいずれか 1 に記載 の皮膚貼付け用積層体の製造方法。 [001 1] [15] [9] to [14], which further includes a step 8 3 of hydrophilizing the surface of the first layer formed in step 8 between step 8 and step 9. 1. The method for producing a laminate for skin application according to any one of 1.

[1 6] 工程八 3にて親水化処理された第 1層の表面は、 1\1 -メチルー 2 —ピロリ ドンとの接触角が 6 0度以下である、 [1 5] に記載の皮膚貼付け 用積層体の製造方法。 [1 6] The surface of the first layer hydrophilically treated in step 83 has a contact angle with 1\1-methyl-2-pyrrolidone of 60° or less, and the skin according to [1 5] Method for manufacturing laminated body for sticking.

[1 7] 工程巳後、 第 2層上に第 2支持体と貼り合わせる工程 0を更に有 する、 [9] 〜 [1 6] のいずれか 1 に記載の皮膚貼付け用積層体の製造方 法。 \¥0 2020/175681 4 卩(:171? 2020 /008363 発明の効果 [17] The method for producing a laminate for skin patch according to any one of [9] to [16], further including a step 0 of laminating the second support on the second layer after the step Law. \\0 2020/175681 4 卩 (: 171? 2020 /008363 Effect of invention

[0012] 本開示の一実施形態によれば、 違和感なく貼付けられ、 皮膚の動きに追従 し、 且つ、 皮膚から放出される水蒸気の透過性に優れる皮膚貼付け用積層体 及びその製造方法を提供することができる。 [0012] According to an embodiment of the present disclosure, there is provided a skin-adhesive laminate which is affixed without any discomfort, follows the movement of the skin, and has excellent permeability of water vapor released from the skin, and a method for producing the same. be able to.

発明を実施するための形態 MODE FOR CARRYING OUT THE INVENTION

[0013] 以下、 本開示の具体的な実施形態の例について詳細に説明するが、 以下の 実施形態は一例に過ぎず、 以下の記載に何ら限定されず、 本発明の目的の範 囲内において、 適宜、 変更を加えて実施することができる。 [0013] Hereinafter, examples of specific embodiments of the present disclosure will be described in detail, but the following embodiments are merely examples and are not limited to the following description, and within the scope of the object of the present invention. It can be implemented with appropriate changes.

[0014] 本明細書において 「〜」 を用いて示された数値範囲は、 「〜」 の前後に記 載される数値をそれぞれ最小値及び最大値として含む範囲を示す。 [0014] In the present specification, the numerical range indicated by "to" indicates the range including the numerical values before and after "to" as the minimum value and the maximum value, respectively.

さらに、 本明細書において組成物に含まれる各成分の量は、 組成物中に、 各成分に該当する物質が複数含まれる場合、 特に断らない限り、 当該複数の 物質の合計量を意味する。 Further, in the present specification, the amount of each component contained in the composition means the total amount of the plurality of substances, unless otherwise specified, when the composition contains a plurality of substances corresponding to the respective components.

本明細書中に段階的に記載されている数値範囲において、 ある数値範囲で 記載された上限値又は下限値は、 他の段階的な記載の数値範囲の上限値又は 下限値に置き換えてもよい。 また、 本明細書中に記載されている数値範囲に おいて、 ある数値範囲で記載された上限値又は下限値は、 実施例に示されて いる値に置き換えてもよい。 In the numerical ranges described stepwise in the present specification, the upper limit value or the lower limit value described in a certain numerical range may be replaced with the upper limit value or the lower limit value of another stepwise described numerical range. .. Further, in the numerical ranges described in the present specification, the upper limit value or the lower limit value described in a certain numerical range may be replaced with the values shown in the examples.

本明細書において、 「 (メタ) アクリル」 は、 アクリル及びメタクリルの 少なくとも一方を意味する。 In the present specification, “(meth)acrylic” means at least one of acrylic and methacrylic.

本明細書において、 2以上の好ましい態様の組み合わせは、 より好ましい 態様である。 In the present specification, a combination of two or more preferred embodiments is a more preferred embodiment.

[0015] <皮膚貼付け用積層体> [0015] <Layer for skin application>

本開示の皮膚貼付け用積層体 (以下、 「本開示の積層体」 ともいう) は、 シリコーンエラストマーを含む第 1層と、 第 1層と接触し且つ粘着性を示す 第 2層と、 を有する。 そして、 本開示の積層体が有する第 1層と第 2層との 積層物は、 4 0 %伸長時の引張応力が〇.

Figure imgf000005_0001
以下であり、 且つ、 総厚 みが 1 01 01以下である。 \¥02020/175681 5 卩(:171? 2020 /008363 A skin patch laminate of the present disclosure (hereinafter, also referred to as “laminate of the present disclosure”) has a first layer containing a silicone elastomer, and a second layer that is in contact with the first layer and exhibits adhesiveness. .. The laminate of the first layer and the second layer of the laminate of the present disclosure has a tensile stress at 40% elongation of ◯.
Figure imgf000005_0001
The total thickness is less than or equal to 101 01. \¥02020/175681 5 卩 (: 171? 2020 /008363

[0016] 本開示の積層体は、 第 1層と第 2層との積層物の、 40%伸長時の引張応 力が〇.

Figure imgf000006_0001
以下であり、 且つ、 総厚みが 1
Figure imgf000006_0002
以下であることで、 違 和感なく貼付けられ、 皮膚の動きに追従するといった効果を奏するものと推 測される。 [0016] The laminate of the present disclosure has a tensile stress of 40% elongation of the laminate of the first layer and the second layer.
Figure imgf000006_0001
Below, and the total thickness is 1
Figure imgf000006_0002
It is presumed that the following will be applied with no discomfort and will have the effect of following the movement of the skin.

更に、 第 1層がシリコーンエラストマーを含む層であることで、 その素材 に由来して、 皮膚からの放出される水蒸気の透過性に優れるといった効果を 奏するものと推測される。 Furthermore, since the first layer is a layer containing a silicone elastomer, it is presumed that the first layer has an effect of being excellent in permeability of water vapor released from the skin due to its material.

[0017] なお、 特開 201 8-043950号公報及び特開 201 6— 02222 [0017] Note that Japanese Patent Laid-Open Nos. 201 8-043950 and 201 6-02222

3号公報に記載の積層体は、 いずれも、 粘着層に隣接する層としてシリコー ンエラストマーを含む層を有していない。 また、 特開 201 8— 04395 〇号公報及び特開 201 6-022223号公報に記載の積層体は、 粘着層 と隣接する層との積層物における引張応力についても何ら検討されていない None of the laminates described in Japanese Patent Publication No. 3 has a layer containing a silicone elastomer as a layer adjacent to the adhesive layer. Further, in the laminates described in JP-A-2010-04395-O and JP-A-2016-022223, the tensile stress in the laminate of the adhesive layer and the adjacent layer is not examined at all.

[0018] [40%伸長時の引張応力] [0018] [Tensile stress at 40% elongation]

本開示の積層体において、 第 1層と第 2層との積層物の 40%伸長時の引 張応力は 0.

Figure imgf000006_0003
以下である。 In the laminate of the present disclosure, the tensile stress at 40% elongation of the laminate of the first layer and the second layer is 0.
Figure imgf000006_0003
It is the following.

積層物の 40%伸長時の引張応力は、 皮膚の動きに追従し易くなる観点か ら、 〇.

Figure imgf000006_0004
以下が好ましく、 〇. 61\/1 3以下がより好ましく、 〇.The tensile stress at 40% elongation of the laminate is easy to follow the movement of the skin.
Figure imgf000006_0004
The following is preferred, and 〇.61\/1 3 or less is more preferred, 〇.

31\/1 3以下が更に好ましい。 31\/13 or less is more preferable.

積層物の 40%伸長時の引張応力の下限値は、 例えば、 〇. 001 IV! 3 である。 The lower limit of tensile stress at 40% elongation of the laminate is, for example, 0.001 IV! 3 .

[0019] また、 本開示の積層体において、 皮膚の動きに追従し易くなる観点から、 第 1層と第 2層との積層物の 1 0%伸長時の引張応力は〇.

Figure imgf000006_0005
以下で あることが好ましく、 〇. 21\/1 3以下であることがより好ましく、 0. 1 IV! 3以下であることが更に好ましい。 [0019] Further, in the laminated body of the present disclosure, from the viewpoint of easily following the movement of the skin, the tensile stress at 10% elongation of the laminated body of the first layer and the second layer is ◯.
Figure imgf000006_0005
It is preferably not more than 0.21, more preferably not more than 0.13 and even more preferably not more than 0.1 IV! 3.

積層物の 1 0%伸長時の引張応力の下限値は、 例えば、 〇. 001 IV! 3 である。 The lower limit of the tensile stress at 10% elongation of the laminate is, for example, 0.001 IV! 3 .

[0020] [引張破断伸度] \¥02020/175681 6 卩(:171? 2020 /008363 [0020] [Tensile breaking elongation] \\02020/175681 6 卩 (: 171? 2020 /008363

本開示の積層体において、 皮膚の動きに追従し易くなる観点から、 第 1層 と第 2層との積層物の引張破断伸度は、 1 00%以上であることが好ましく 、 1 50%以上であることがより好ましく、 200%以上であることが更に 好ましい。 In the laminate of the present disclosure, from the viewpoint of easily following the movement of the skin, the tensile elongation at break of the laminate of the first layer and the second layer is preferably 100% or more, and 150% or more. Is more preferable and 200% or more is further preferable.

積層物の引張破断伸度の上限値は、 例えば、 900%である。 The upper limit of the tensile elongation at break of the laminate is, for example, 900%.

[0021] 積層物の引張応力及び引張破断伸度を上記の範囲にするためには、 第 1層 の引張応力及び引張破断伸度を調整する方法、 第 2層の引張応力及び引張破 断伸度を調整する方法、 第 1層と第 2層その膜厚比を調整する方法等が挙げ られる。 [0021] In order to bring the tensile stress and the tensile elongation at break of the laminate into the above ranges, the method for adjusting the tensile stress and the tensile elongation at break of the first layer, the tensile stress and the tensile elongation at break of the second layer are adjusted. And a method of adjusting the film thickness ratio between the first layer and the second layer.

皮膚への粘着性を示す第 2層を第 1層に比べ薄くする場合、 積層物の引張 応力及び引張破断伸度は、 積層物中の第 1層の引張応力及び引張破断伸度を 調整する方法にて制御することが好ましい。 When making the second layer, which is adhesive to the skin, thinner than the first layer, the tensile stress and tensile elongation at break of the laminate should be adjusted by adjusting the tensile stress and tensile elongation at break of the first layer in the laminate. It is preferable to control by a method.

[0022] (測定) [0022] (Measurement)

ここで、 積層物における 40%伸長時の引張応力及び引張破断伸度は、 以 下のようにして測定する。 Here, the tensile stress at 40% elongation and the tensile elongation at break in the laminate are measured as follows.

まず、 測定対象物から幅 2〇 、 チャック間距離 4〇 の試験片を 3 つ作製する。 引張り試験機 (例えば、 島津製作所のオートグラフ八〇 3— X ) にて、 3つの試験片それぞれについて引張速度 50 /〇! 丨 にて伸長 する。 そして、 以下の式 (1) を用いて引張応力を、 また、 以下の式 (2) を用いて引張破断伸度を求める。 3つの試験片のそれぞれから求められた引 張応力及び引張破断伸度を平均したものを、 積層物における引張応力及び引 張破断伸度とする。 First, prepare three test pieces with a width of 20 and a chuck-to-chuck distance of 40 from the measurement object. Using a tensile tester (for example, Autograph 803-X manufactured by Shimadzu Corporation), stretch each of the three test pieces at a pulling speed of 50/〇! 丨. Then, the tensile stress is calculated using the following equation (1), and the tensile fracture elongation is calculated using the following equation (2). The tensile stress and tensile elongation at break in the laminate are obtained by averaging the tensile stress and tensile elongation at break obtained from each of the three test pieces.

なお、 試験片の伸長は、 25±2°〇の環境下で行う。 The test piece shall be extended in an environment of 25 ± 2 ° .

式 (1) 引張応力

Figure imgf000007_0001
= /八 Formula (1) Tensile stress
Figure imgf000007_0001
= / Eight

式 (1) 中、 は、 試験片が 40%伸長した時の荷重 (1\!) を表し、 八は 、 伸長前の試験片の断面積 ( 〇!2、 具体的には、 20〇1111\乂111111、 Xは試 験片の厚み) を表す。 In the formula (1), represents the load (1\!) when the test piece is stretched by 40%, and 8 is the cross-sectional area of the test piece before extension (○! 2 , specifically, 20○1111). \111111, X represents the thickness of the test piece).

式 (2) 引張破断伸度 (%) = (02-01) /01 X 1 00 \¥0 2020/175681 7 卩(:171? 2020 /008363 Formula (2) Tensile breaking elongation (%) = (02-01) /01 X 100 \¥0 2020/175681 7 卩 (: 171? 2020 /008363

式 (2) 中、

Figure imgf000008_0001
チャック間距離 ( ) を表し、 0 2は、 破断時の チャック間距離 (01 111) を表す。 In formula (2),
Figure imgf000008_0001
The chuck-to-chuck distance () is represented, and 0 2 is the chuck-to-chuck distance (01 111) at break.

なお、 1 〇%伸長時の引張応力は、 上記式 (1) の に、 試験片が 1 0 % 伸長した時の荷重 (1\〇 を導入すること以外は、 1 0 %伸長時の引張応力と 同様の方法で求められる。 The tensile stress at 10% elongation is the tensile stress at 10% elongation except that the load (1\○) when the test piece is expanded by 10% is added to the above formula (1). It is calculated in the same way as.

[0023] [総厚み] [0023] [Total thickness]

本開示の積層体において、 第 1層と第 2層との積層物の総厚みは 1 〇1〇1以 下である。 In the laminate of the present disclosure, the total thickness of the laminate of the first layer and the second layer is 1101 or less.

総厚みが 1

Figure imgf000008_0002
以下であることで、 皮膚への貼付け時に、 重さ、 異物感等 を感じにくくなり、 違和感なく貼付けられる。 Total thickness is 1
Figure imgf000008_0002
The following items make it less likely to feel weight and foreign matter when applied to the skin, so that the product can be applied comfortably.

積層物の総厚みは、 薄ければ薄いほど違和感なく貼り付けられる。 具体的 には、 積層物の総厚みは、 〇.

Figure imgf000008_0003
7 が好ましく、 0 . 0 1 01 01〜〇. 5 01 01がより好ましく、 〇.
Figure imgf000008_0004
が更に好ま しく、 〇. 0 2〇1 111 ~〇. 1 01 111が特に好ましい。 The thinner the total thickness of the laminate, the more comfortable the attachment. Specifically, the total thickness of the laminate is:
Figure imgf000008_0003
7 is preferable, 0.0 1 01 01 to ○ 0.5 01 01 is more preferable, and ○.
Figure imgf000008_0004
Is more preferable, and 0.02 ○ 1 111 to ○ 0.11 111 is particularly preferable.

また、 積層体の総厚みの下限値は、 製造適性の観点から、 例えば、 〇. 〇 0 3 01 01が挙げられる。 Further, the lower limit of the total thickness of the laminated body is, for example, from the viewpoint of manufacturing suitability, 0.00 0.001 01.

[0024] (測定) [0024] (Measurement)

ここで、 第 1層と第 2層との積層物における総厚みは、 以下のようにて測 定する。 Here, the total thickness of the laminate of the first layer and the second layer is measured as follows.

厚みの測定には、 定圧厚さ測定器 (スタンドタイプデジタル測厚器、 〇 - 2 0」、 テクロック社製) を使用する。 To measure the thickness, use a constant pressure thickness gauge (stand type digital thickness gauge, 〇-20", manufactured by Teclock Co.).

測定には、 第 1支持体/第 1層/第 2層/第 2支持体で構成された積層物 が適用され、 この積層物の総厚みから第 1支持体と第 2支持体との厚さを差 し引くことで、 第 1層と第 2層との総厚みを求める。 そのため、 予め、 第 1 支持体及び第 2支持体のそれぞれ単体の厚みを上記の定圧厚さ測定器にて測 定しておく。 For the measurement, a laminate composed of the first support/first layer/second layer/second support was applied, and the thickness of the first support and the second support was calculated from the total thickness of this stack. The total thickness of the first and second layers is obtained by subtracting the thickness. Therefore, the thickness of each of the first support and the second support should be measured beforehand with the above-mentioned constant pressure thickness gauge.

なお、 測定に用いる積層物の試験片は、 既述の引張応力及び引張破断伸度 の測定に用いる試験片と同じ形状のものであって、 3つ用意する。 \¥0 2020/175681 8 卩(:171? 2020 /008363 The test pieces of the laminate used for the measurement have the same shape as the test pieces used for the measurement of the tensile stress and the tensile elongation at break, and three pieces are prepared. \¥0 2020/175681 8 卩 (: 171? 2020 /008363

試験片の中央部を上記の定圧厚さ測定器にて 3回測定し、 3回の平均値を その試験片における厚みとする。 3つの試験片に対し同様の測定を行い、 3 試験片の厚みの平均値を第 1層と第 2層との積層物における総厚みの厚みと する。 The center of the test piece is measured 3 times with the above-mentioned constant pressure thickness gauge, and the average value of 3 times is taken as the thickness of the test piece. The same measurement is performed on three test pieces, and the average value of the thickness of the three test pieces is taken as the total thickness of the laminate of the first layer and the second layer.

[0025] なお、 第 1層のみの厚みを測定する場合には、 測定には、 第 1支持体/第 [0025] When measuring the thickness of only the first layer, the first support/first layer is used for the measurement.

1層/保護フィルムで構成された積層物を適用すればよい。 この積層物の総 厚みから、 第 1支持体と保護フィルムとの厚さを差し引くことで、 第 1層の 厚みが求められる。 そのため、 予め、 第 1支持体に加え、 保護フィルム単体 の厚みを上記の定圧厚さ測定器にて測定しておく。 A laminate composed of one layer/protective film may be applied. The thickness of the first layer can be determined by subtracting the thickness of the first support and the protective film from the total thickness of this laminate. Therefore, in addition to the first support, measure the thickness of the protective film alone with the above-mentioned constant pressure thickness measuring device.

第 1支持体/第 1層/保護フィルムで構成された積層物は、 例えば、 後述 する皮膚貼付け用積層体の製造方法における工程 1 を経て得られた第 1支 持体/第 1層/保護フィルムで構成された積層物が挙げられる。 The laminate composed of the first support/first layer/protective film is, for example, the first support/first layer/protection obtained through step 1 in the method for producing a skin patch laminate described later. A laminate composed of a film may be mentioned.

また、 上記の方法で得られた第 1層と第 2層との総厚みから、 第 1層のみ の厚みを差し引くことで、 第 2層の厚みも算出することができる。 The thickness of the second layer can also be calculated by subtracting the thickness of only the first layer from the total thickness of the first layer and the second layer obtained by the above method.

[0026] 以下、 本開示の積層体が有する第 1層及び第 2層について説明する。 [0026] Hereinafter, the first layer and the second layer of the laminate of the present disclosure will be described.

[0027] [第 1層] [0027] [First layer]

本開示の積層体は、 シリコーンエラストマーを含む第 1層を有する。 第 1 層は、 シリコーンエラストマーの他、 シリカ粒子を含んでいてもよい。 第 1層は、 単層構造であってもよいし、 多層構造であってもよい。 第 1層 が多層構造の場合、 そのうちの少なくとも 1層がシリコーンエラストマーを 含んでいればよい。 The laminate of the present disclosure has a first layer that includes a silicone elastomer. The first layer may contain silica particles in addition to the silicone elastomer. The first layer may have a single-layer structure or a multi-layer structure. When the first layer has a multi-layer structure, at least one of the layers may contain a silicone elastomer.

なお、 第 1層が多層構造の場合、 それぞれの層にて、 シリコーンエラスト マーの架橋密度が異なっていてもよい。 また、 第 1層が多層構造の場合、 そ れそれの層にて、 シリカ粒子の添加の有無を変えてもよいし、 シリカ粒子の 含有量が異なっていてもよい。 When the first layer has a multi-layer structure, the respective layers may have different cross-linking densities of the silicone elastomer. When the first layer has a multilayer structure, the presence or absence of addition of silica particles may be changed in each layer, or the content of silica particles may be different.

[0028] (シリコーンエラストマー) [0028] (Silicone elastomer)

シリコーンエラストマーは、 シリコーンポリマーの架橋物を指し、 シリコ —ンポリマーの三次元架橋物であることが好ましい。 \¥02020/175681 9 卩(:171? 2020 /008363 The silicone elastomer refers to a crosslinked product of a silicone polymer, and is preferably a three-dimensional crosslinked product of a silicone polymer. \\02020/175681

シリコーンポリマーの三次元架橋物は、 より具体的には、 架橋性基を有す るシリコーンポリマーと架橋剤とによる反応生成物であることが好ましい。 More specifically, the three-dimensional crosslinked product of the silicone polymer is more preferably a reaction product of a silicone polymer having a crosslinkable group and a crosslinking agent.

[0029] 架橋性基を有するシリコーンポリマーとしては、 分子内に 2つ以上の架橋 性基を有する、 ポリジメチルシロキサン、 ポリメチルフエニルシロキサン、 ポリメチルジフエニルシロキサン等が好ましいものとして挙げられ、 中でも 、 使用実績の観点及び三次元架橋物が得られやすい観点から、 分子内に 2つ 以上の架橋性基を有するポリジメチルシロキサンが好ましく、 特に、 両主鎖 末端に架橋性基を有するポリジメチルシロキサンが好ましい。 [0029] Examples of the silicone polymer having a crosslinkable group include polydimethylsiloxane, polymethylphenylsiloxane, polymethyldiphenylsiloxane, and the like, which have two or more crosslinkable groups in the molecule. From the viewpoint of actual use and the ease of obtaining a three-dimensional crosslinked product, polydimethylsiloxane having two or more crosslinkable groups in the molecule is preferable, and polydimethylsiloxane having crosslinkable groups at both main chain terminals is particularly preferable. Is preferred.

[0030] シリコーンポリマーが有する架橋性基としては、 シリコーンポリマーの架 橋反応として公知の、 ヒドロシリル化、 有機過酸化物による反応、 脱酢酸、 脱水、 脱アルコール等の反応に用いられる官能基であればよい。 中でも、 シ リコーンポリマーの架橋反応としては、 反応副生成物が生じないヒドロシリ ル化が好ましく、 架橋性基としては、 ビニル基が特に好ましい。 The crosslinkable group contained in the silicone polymer may be a functional group used in reactions such as hydrosilylation, reaction with organic peroxide, deacetic acid, dehydration, dealcoholization, etc., which is known as a crosslinking reaction of silicone polymers. Good. Among them, as the crosslinking reaction of the silicone polymer, hydrosilylation that does not generate a reaction by-product is preferable, and as the crosslinking group, a vinyl group is particularly preferable.

即ち、 架橋性基を有するシリコーンポリマーとしては、 特に、 両主鎖末端 にビニル基を有するポリジメチルシロキサンが好ましい。 That is, as the silicone polymer having a crosslinkable group, polydimethylsiloxane having vinyl groups at both main chain terminals is particularly preferable.

[0031] 架橋性基を有するシリコーンポリマーの重量平均分子量としては、 特に制 限はないが、 例えば、 800〜 50000が挙げられ、 1 0000〜 300 00が好ましい。 The weight average molecular weight of the silicone polymer having a crosslinkable group is not particularly limited, but examples thereof include 800 to 50,000, and preferably 10,000 to 300,000.

架橋性基を有するシリコーンポリマーは、 1種単独で用いられてもよいし 、 2種以上を併用してもよい。 The silicone polymer having a crosslinkable group may be used alone or in combination of two or more.

架橋性基を有するシリコーンポリマーの重量平均分子量は、 ゲルパーミエ —シヨンクロマトグラフィ (〇 〇) で測定できる。 具体的には、 1~11_〇一 81 20〇 〇、 30-8020 (東ソー株式会社) を用い、 カラムとして 、 丁3 < 96 1、 3リ 6 「 1~11\/1— 1~1 (東ソー株式会社、 6.

Figure imgf000010_0001
The weight average molecular weight of the silicone polymer having a crosslinkable group can be measured by gel permeation chromatography (XX). Specifically, 1 ~ 11_ 〇 81 81 〇 〇, 30-8020 (Tosoh Corporation) was used, and the column was D3 3 <96 1, 3 Li 6 “1 ~ 11\/1— 1 ~ 1 (Tosoh Corporation, 6.
Figure imgf000010_0001

1 5〇〇!) を 2本用い、 溶離液としてテトラヒドロフラン (丁 1~1 ) を用い て測定できる。 また、 条件としては、 試料濃度を〇. 5質量%、 流速を〇.It can be measured by using two (1500!) and tetrahydrofuran (D1 to 1) as the eluent. As conditions, sample concentration is 0.5 mass% and flow rate is 0.9.

6

Figure imgf000010_0002
、 サンプル注入量を 1 0 丨 (マイクロリツ トル) 、 測定温 度を 40 °〇とし、 示差屈折計 ([¾ 丨) 検出器を用いて行なうことができる。 \¥02020/175681 10 卩(:171?2020/008363 6
Figure imgf000010_0002
The sample injection amount can be set to 10 (microliter), the measurement temperature can be set to 40 ° , and a differential refractometer ([¾]) detector can be used. \¥02020/175681 10 ((171?2020/008363

検量線は、 東ソー社 「 〇 I

Figure imgf000011_0002
㊀標準試料丁 3
Figure imgf000011_0001
The calibration curve is based on Tosoh Corporation “○I
Figure imgf000011_0002
㊀ Standard sample knife 3
Figure imgf000011_0001

3 4」 : 「八- 500」 、 「 - 1」 、 「 - 1 0」 、 「 -80」 、 「 -380」 、 「八- 2500」 、 「 -4」 、 「 -40」 、 「 - 1 2 8」 、 「 ー 700」 の 1 0サンプルから作製されたものを用いることがで きる。 34: "8-500", "-1", "-10", "-80", "-380", "eight-2,500", "-4", "-40", "-1" It is possible to use those made from 10 samples of "28" and "-700".

[0032] 架橋剤としては、 架橋性基を有するシリコーンポリマーの架橋性基と反応 する官能基を有するものであれば特に制限はないが、 架橋密度の制御し易さ の観点から、 シロキサン化合物であることが好ましい。 [0032] The cross-linking agent is not particularly limited as long as it has a functional group that reacts with the cross-linking group of the silicone polymer having a cross-linking group, but from the viewpoint of easy control of the cross-linking density, a siloxane compound is used. Preferably.

架橋剤として具体的には、 分子内に 2つ以上のヒドロシリル基を有するシ ロキサン化合物が好ましく、 具体的には、 ポリメチルヒドロシロキサン、 メ チルヒドロシロキサンとジメチルシロキサンとの共重合体、 ポリメチルフエ ニルシロキサン又はポリメチルジフエニルシロキサンとポリメチルヒドロシ ロキサンとの共重合体等が挙げられる。 As the cross-linking agent, specifically, a siloxane compound having two or more hydrosilyl groups in the molecule is preferable. Specifically, polymethylhydrosiloxane, a copolymer of methylhydrosiloxane and dimethylsiloxane, polymethylphenyl is preferable. Examples thereof include copolymers of siloxane or polymethyldiphenylsiloxane and polymethylhydrosiloxane.

架橋剤としては、 特に、 メチルヒドロシロキサンとジメチルシロキサンと の共重合体が好ましい。 As the cross-linking agent, a copolymer of methylhydrosiloxane and dimethylsiloxane is particularly preferable.

[0033] 架橋剤として好ましいシロキサン化合物の重量平均分子量としては、 特に 制限はないが、 例えば、 500〜 30000が挙げられ、 1 0000〜 25 000が好ましい。 [0033] The weight average molecular weight of the siloxane compound that is preferable as the crosslinking agent is not particularly limited, but examples thereof include 500 to 30,000, and preferably 10,000 to 25,000.

シロキサン化合物の重量平均分子量は、 架橋性基を有するシリコーンポリ マーの重量平均分子量の測定方法と同じ方法で測定される。 The weight average molecular weight of the siloxane compound is measured by the same method as the weight average molecular weight of the silicone polymer having a crosslinkable group.

架橋剤は、 1種単独で用いられてもよいし、 2種以上を併用してもよい。 The crosslinking agents may be used alone or in combination of two or more.

[0034] 架橋性基を有するシリコーンポリマーと架橋剤との量比は、 第 1層に求め られる引張応力及び引張破断伸度に応じて決定されればよい。 [0034] The amount ratio of the silicone polymer having a crosslinkable group and the crosslinking agent may be determined according to the tensile stress and the tensile elongation at break required for the first layer.

架橋性基を有するシリコーンポリマーと架橋剤との量比は、 例えば、 質量 比にて、 架橋性基を有するシリコーンポリマー:架橋剤 =7 : 3〜 9 : 1が 好ましく、 3 : 1〜 1 9 : 1が好ましく、 4 : 1〜 1 9 : 1がより好ましく 、 1 7 : 3〜 9 : 1が更に好ましい。 The amount ratio of the cross-linkable group-containing silicone polymer and the cross-linking agent is, for example, in terms of mass ratio, the cross-linkable group-containing silicone polymer:crosslinking agent=7:3 to 9:1 is preferable, and 3:1 to 19 :1 is preferable, 4:1 to 19:1 is more preferable, and 17:3 to 9:1 is further preferable.

[0035] 第 1層に含まれるシリコーンエラストマーは、 上記のように、 ヒドロシリ \¥0 2020/175681 1 1 卩(:171? 2020 /008363 [0035] As described above, the silicone elastomer contained in the first layer is \\0 2020/175681 1 1 卩 (: 171? 2020 /008363

ル化反応による架橋構造を有するものが好ましい。 Those having a cross-linking structure due to the sulfation reaction are preferable.

ヒドロシリル化反応による架橋構造の存在は、 第 1層中の、 ビニル基の有 無、 及び、 金属触媒の有無の少なくとも一方 (好ましくは両方) を確認する ことで推定することができる。 The presence of the crosslinked structure due to the hydrosilylation reaction can be estimated by confirming the presence or absence of a vinyl group and the presence or absence of a metal catalyst (preferably both) in the first layer.

ヒドロシリル化反応による架橋構造を有するシリコーンエラストマー中に は、 通常、 未反応のビニル基が残存する。 そのため、 第 1層中に残存するビ ニル基の有無を確認することで、 シリコーンエラストマー中のヒドロシリル 化反応による架橋構造の存在が推定される。 In the silicone elastomer having a crosslinked structure by the hydrosilylation reaction, unreacted vinyl groups usually remain. Therefore, by confirming the presence or absence of a vinyl group remaining in the first layer, the existence of a crosslinked structure due to the hydrosilylation reaction in the silicone elastomer is estimated.

また、 ヒドロシリル化反応には、 後述するように金属触媒が用いられるこ とがある。 そのため、 第 1層中の金属触媒の有無を確認することで、 シリコ —ンエラストマー中のヒドロシリル化反応による架橋構造の存在が推定され る。 Further, a metal catalyst may be used in the hydrosilylation reaction as described later. Therefore, by confirming the presence or absence of the metal catalyst in the first layer, the existence of a crosslinked structure due to the hydrosilylation reaction in the silicone elastomer is estimated.

[0036] ビニル基の有無は、 第 1層中に残存するビニル基を、 核磁気共鳴分光法等 を用いることで確認できる。 核磁気共鳴分光法には、 例えば、 ブルカー社製 八 八1\1〇巳 III

Figure imgf000012_0001
6 0 0が用いられる。 [0036] The presence or absence of the vinyl group can be confirmed by using the nuclear magnetic resonance spectroscopy or the like for the vinyl group remaining in the first layer. Nuclear magnetic resonance spectroscopy can be performed, for example, by Bruker 888 1\100 Ⅲ
Figure imgf000012_0001
600 is used.

また、 金属触媒の有無は、 蛍光 X線分析法等により金属元素 (プラチナ、 チタン等) を分析することで確認できる。 蛍光 X線分析法には、 例えば、 ( 株) リガク製 「 丨 01リ 3 11型乂[¾ が用いられる。 The presence or absence of a metal catalyst can be confirmed by analyzing metal elements (platinum, titanium, etc.) by X-ray fluorescence analysis. For the fluorescent X-ray analysis method, for example, “R011 type 311 manufactured by Rigaku Corporation” is used.

[0037] 第 1層に後述するシリカ粒子が含まれない場合、 シリコーンエラストマー (即ち、 シリコーンポリマーの架橋物) の含有量は、 第 1層の全質量に対し て、 7 0質量%〜 1 0 0質量%が好ましく、 7 5質量%〜 1 0 0質量%がよ り好ましく、 8 0質量%〜 1 0 0質量%が更に好ましい。 [0037] When the first layer does not contain silica particles described below, the content of the silicone elastomer (that is, a cross-linked product of the silicone polymer) is 70% by mass to 10% with respect to the total mass of the first layer. 0 mass% is preferable, 75 mass% to 100 mass% is more preferable, and 80 mass% to 100 mass% is further preferable.

第 1層に後述するシリカ粒子が含まれる場合、 シリコーンエラストマ _ ( 即ち、 シリコーンポリマーの架橋物) の含有量は、 第 1層の全質量に対して 、 7 0質量%〜 9 3質量%が好ましく、 7 5質量%〜 9 3質量%がより好ま しく、 8 0質量%〜 9 0質量%が更に好ましい。 When the first layer contains silica particles described below, the content of silicone elastomer _ (that is, a cross-linked product of silicone polymer) is 70% by mass to 93% by mass with respect to the total mass of the first layer. 75% by mass to 93% by mass is more preferable, and 80% by mass to 90% by mass is further preferable.

[0038] (シリカ粒子) [0038] (silica particles)

第 1層は、 シリカ粒子を含んでいることが好ましい。 \¥0 2020/175681 12 卩(:171? 2020 /008363 The first layer preferably contains silica particles. \¥0 2020/175681 12 卩 (: 171? 2020 /008363

シリカ粒子を含むことで、 第 1層の引張応力及び引張破断伸度の制御がし やすくなる。 ここで、 第 1層にシリカ粒子が含まれることの確認は以下の ようにして行う。 The inclusion of silica particles makes it easier to control the tensile stress and tensile fracture elongation of the first layer. Here, it is confirmed that the first layer contains silica particles as follows.

即ち、 第 1層を溶解し、 溶解液を透過型電子顕微鏡 (丁巳!\/1) にて観察す ることで、 シリカ粒子の有無を直接的に確認することができる。 透過型電子 顕微鏡としては、 例えば、 は日本電子 (株) の」 巳1\/1 - 1 2 0 0巳乂型 巳 —丁巳1\/1を用いればよく、 測定の際の加速電圧は 1 2 0 1< とすればよい。 なお、 第 1層の溶解液は、 第 1層を、 オルトギ酸メチル、 メタノール性塩 酸、 及びトルエンの混合液に浸潰し、 撹拌することで作製することができる That is, the presence or absence of silica particles can be directly confirmed by dissolving the first layer and observing the dissolved solution with a transmission electron microscope (Chomi!\/1). As a transmission electron microscope, for example, is a JEOL Ltd.'s "1\/1-1 2 0 0 跳跂跳-Cho 1\/1", and the acceleration voltage at the time of measurement is 1 2 0 1 < The solution for the first layer can be prepared by immersing the first layer in a mixed solution of methyl orthoformate, methanolic hydrochloric acid, and toluene, and stirring the solution.

[0039] シリカ粒子としては、 特に制限はなく、 ヒュームドシリカ及びコロイダル シリカのいずれであってもよく、 また、 結晶性であってもよいし、 非晶性で あってもよい。 [0039] The silica particles are not particularly limited, and may be any of fumed silica and colloidal silica, and may be crystalline or amorphous.

特に、 シリコーン系溶剤への分散性、 シリコーンポリマーの架橋物への分 散性、 及び、 塗布液粘度の安定性の観点から、 ヒュームドシリカが好ましい また、 シリカ粒子の形状としては、 特に限定はなく、 球状、 板状、 針状、 数珠状、 又はこれらの 2種類以上が合体した形状が挙げられる。 In particular, fumed silica is preferable from the viewpoints of dispersibility in a silicone solvent, dispersibility in a crosslinked product of a silicone polymer, and stability of coating solution viscosity. The shape of silica particles is not particularly limited. However, a spherical shape, a plate shape, a needle shape, a bead shape, or a shape in which two or more kinds of these are combined is included.

[0040] シリカ粒子としては、 第 1層中への分散性の観点、 平均一次粒径が 3 n

Figure imgf000013_0001
[0040] The silica particles have an average primary particle size of 3 n from the viewpoint of dispersibility in the first layer.
Figure imgf000013_0001

好ましく、 7 1^ 111〜 4 0 01であることが更に好ましい。 It is more preferably 71^111 to 4001.

シリカ粒子の平均一次粒径は、 第 1層を透過型電子顕微鏡 (丁巳 IV!) にて 観察することでよって測定される。 より具体的には、 シリカ粒子の平均一次 粒子径は、 シリカ粒子の形状が球状又は断面楕円状の略球状である場合、 第 1層中に分散したシリカ粒子を透過型電子顕微鏡により観察し、 得られた観 察写真から 3 0 0個以上の粒子について粒子の投影面積を測定し、 投影面積 から円相当径を求め、 得られた円相当径をシリカ粒子の平均一次粒子径とす る。 シリカ粒子の形状が、 球状又は略球状ではない場合には、 その他の方法 \¥0 2020/175681 13 卩(:171? 2020 /008363 The average primary particle size of the silica particles is measured by observing the first layer with a transmission electron microscope (Cho IV!). More specifically, the average primary particle diameter of the silica particles is, when the shape of the silica particles is spherical or substantially spherical with an elliptical cross section, the silica particles dispersed in the first layer are observed by a transmission electron microscope, From the obtained observation photograph, the projected area of 300 or more particles is measured, the equivalent circle diameter is determined from the projected area, and the obtained equivalent circle diameter is taken as the average primary particle diameter of silica particles. If the shape of silica particles is not spherical or nearly spherical, use another method. \\0 2020/175681 13 卩 (: 171? 2020 /008363

、 例えば、 動的光散乱法を用いて、 シリカ粒子の平均一次粒子径を求める。 , For example, using a dynamic light scattering method, the average primary particle diameter of silica particles is determined.

[0041 ] シリカ粒子の巳巳丁法による比表面積としては、 第 1層中への分散性の観 点、 第 1層の力学物性の面内分布を少なくする観点、 製造安定性の観点から 、 5 0 2 / 9〜 6 0 0 2/ 9であることが好ましく、 2 0 0〇! 2/ 〜 4 0[0041] As the specific surface area of the silica particles by the Mitsumi method, from the viewpoint of dispersibility in the first layer, the viewpoint of reducing the in-plane distribution of the mechanical properties of the first layer, and the viewpoint of manufacturing stability, 5 0 2 /9 to 600 0 2 /9 is preferable, 2 00 0! 2 / to 40

0 01 2 / 9であることがより好ましい。 It is more preferably 0 01 2 /9.

[0042] 第 1層がシリカ粒子を含む場合、 シリカ粒子の含有量としては、 第 1層の 弓 I張応力及び引張破断伸度を制御し易い観点から、 第 1層の全質量に対して 、 7質量%〜 3 0質量%が好ましく、 7質量%〜 2 5質量%がより好ましく 、 1 〇質量%〜 2 0質量%が更に好ましい。 [0042] When the first layer contains silica particles, the content of the silica particles is such that the bow I tensile stress and the tensile elongation at break of the first layer can be easily controlled with respect to the total mass of the first layer. , 7 mass% to 30 mass% is preferable, 7 mass% to 25 mass% is more preferable, and 10 mass% to 20 mass% is further preferable.

[0043] (その他の成分) [0043] (Other ingredients)

第 1層には、 上述した、 シリコーンエラストマー (即ち、 シリコーンポリ マーの架橋物) 及びシリカ粒子以外にも、 その他の成分を含んでいてもよい その他の成分としては、 シリコーンエラストマー (即ち、 シリコーンポリ マーの架橋物) を得る際に用いられる、 反応触媒等が挙げられる。 その他の 成分としては、 更に、 顔料などの着色剤等を用いてもよい。 The first layer may contain other components in addition to the above-mentioned silicone elastomer (that is, a crosslinked product of silicone polymer) and silica particles. Other components include a silicone elastomer (that is, a silicone polymer). (A crosslinked product of mer), and a reaction catalyst and the like used. As other components, a coloring agent such as a pigment may be used.

[0044] なお、 シリコーンエラストマーを得る際に用いられる反応触媒としては、 シリコーンポリマーの三次元架橋物を得るための反応促進に寄与するもので あればよい。 特に、 反応触媒としては、 ヒドロシリル化反応を促進するため の触媒であることが好ましい。 The reaction catalyst used when obtaining the silicone elastomer may be any catalyst that contributes to the promotion of the reaction for obtaining the three-dimensional crosslinked product of the silicone polymer. In particular, the reaction catalyst is preferably a catalyst for promoting the hydrosilylation reaction.

反応触媒としては、 具体的には、 金属触媒が挙げられ、 特に、 皮膚に対す る刺激が低い観点から、 プラチナ、 チタン、 金、 銀等が挙げられる。 Specific examples of the reaction catalyst include metal catalysts, and in particular, platinum, titanium, gold, silver and the like are mentioned from the viewpoint of low irritation to the skin.

中でも、 触媒としては、 反応促進効率が高く、 皮膚に対する刺激が低い観 点から、 チタン及びプラチナが好ましい。 Among them, titanium and platinum are preferable as the catalyst from the viewpoint of high reaction promoting efficiency and low skin irritation.

プラチナ触媒としては、 シリコーンポリマーの三次元架橋物を得るための 反応促進に寄与する公知のプラチナ触媒 (好ましくはプラチナ錯体) が適用 できる。 As the platinum catalyst, a known platinum catalyst (preferably platinum complex) that contributes to reaction promotion for obtaining a three-dimensional crosslinked product of a silicone polymer can be applied.

[0045] 第 1層の厚みとしては、 貼付け時の重量感などの違和感を抑える観点、 及 \¥0 2020/175681 14 卩(:171? 2020 /008363 [0045] The thickness of the first layer is from the viewpoint of suppressing a feeling of discomfort such as a feeling of weight during attachment, and \¥0 2020/175681 14 卩 (: 171? 2020 /008363

び、 衣服等の外乱に対する剥がれ抑止の観点から、 〇. 7

Figure imgf000015_0001
以下が好まし く、 〇.
Figure imgf000015_0002
以下がより好ましく、 〇. 1
Figure imgf000015_0003
以下が更に好ましい。 And from the standpoint of preventing peeling of clothing and other items against external disturbances.
Figure imgf000015_0001
The following are preferred:
Figure imgf000015_0002
The following are more preferable:
Figure imgf000015_0003
The following is more preferable.

[0046] [第 2層] [0046] [Second layer]

本開示の積層体は、 既述の第 1層と接触し且つ粘着性を示す第 2層を有す る。 The laminate of the present disclosure has a second layer that is in contact with the above-mentioned first layer and exhibits tackiness.

第 2層は、 皮膚に貼付けられる層に該当することから、 皮膚に対して粘着 性を示す層であればよい。 Since the second layer corresponds to the layer attached to the skin, it may be any layer that is adhesive to the skin.

ここで、 「粘着性」 とは、 粘りつく性質であって、 一時的な接着に用いら れ、 後に剥離することができる性質を示す。 Here, the term "adhesiveness" refers to a property of stickiness, which is used for temporary adhesion and can be peeled off later.

[0047] (粘着剤) [0047] (Adhesive)

第 2層は、 粘着剤を含む層であることが好ましい。 The second layer is preferably a layer containing an adhesive.

粘着剤としては、 特に制限はなく、 公知の粘着剤が用いられる。 粘着剤として具体的には、 シリコーン系粘着剤、 アクリル系粘着剤、 ゴム 系粘着剤、 ウレタン系粘着剤等が挙げられる。 The pressure-sensitive adhesive is not particularly limited, and known pressure-sensitive adhesives can be used. Specific examples of the pressure sensitive adhesive include silicone pressure sensitive adhesive, acrylic pressure sensitive adhesive, rubber pressure sensitive adhesive and urethane pressure sensitive adhesive.

中でも、 皮膚への刺激が低い観点、 及び、 第 1層との密着性の観点から、 シリコーン系粘着剤が好ましい。 Above all, a silicone-based pressure-sensitive adhesive is preferable from the viewpoint of low irritation to the skin and from the viewpoint of adhesion to the first layer.

[0048] シリコーン系粘着剤 [0048] Silicone adhesive

本開示におけるシリコーン系粘着剤は、 シリコーンポリマーをべースポリ マー (ポリマー成分のうちの主成分、 すなわちポリマー成分全体の 5 0質量 %以上を占める成分) とする粘着剤を意味する。 The silicone-based pressure-sensitive adhesive in the present disclosure means a pressure-sensitive adhesive that uses a silicone polymer as a base polymer (a main component among polymer components, that is, a component that accounts for 50% by mass or more of the entire polymer component).

シリコーン系粘着剤としては、 特に制限はなく、 公知のシリコーン系粘着 剤が用いられる。 The silicone adhesive is not particularly limited, and known silicone adhesives can be used.

シリコーン系粘着剤として具体的には、 付加反応型シリコーン系粘着剤、 過酸化物硬化型シリコーン系粘着剤、 縮合型シリコーン系粘着剤等が挙げら れる。 中でも、 反応副生成物が発生しないという観点からは、 ヒドロシリル 化による付加反応型シリコーン系粘着剤が好ましい。 Specific examples of the silicone-based pressure-sensitive adhesive include an addition reaction-type silicone-based pressure-sensitive adhesive, a peroxide-curable silicone-based pressure-sensitive adhesive, and a condensation-type silicone-based pressure-sensitive adhesive. Above all, an addition reaction type silicone-based pressure-sensitive adhesive by hydrosilylation is preferable from the viewpoint that reaction by-products are not generated.

[0049] 特に、 第 1層との密着性の観点、 及び製造適性の観点から、 第 1層と同様 の、 架橋性基を有するシリコーンポリマーと架橋剤とを含む付加反応型シリ \¥0 2020/175681 15 卩(:171? 2020 /008363 [0049] In particular, from the viewpoints of adhesion to the first layer and production suitability, an addition reaction type silicone containing the same silicone polymer having a crosslinkable group and the crosslinking agent as the first layer. \¥0 2020/175681 15 卩 (: 171? 2020 /008363

コーン系粘着剤であることが好ましい。 It is preferably a corn adhesive.

即ち、 シリコーン系粘着剤としては、 例えば、 両主鎖末端にビニル基を有 するポリジメチルシロキサンと、 メチルヒドロシロキサンとジメチルシロキ サンとの共重合体と、 を含むことが好ましい。 That is, the silicone-based pressure-sensitive adhesive preferably contains, for example, polydimethylsiloxane having vinyl groups at both ends of the main chain, and a copolymer of methylhydrosiloxane and dimethylsiloxan.

また、 シリコーン系粘着剤は、 反応触媒を含んでいてもよい。 Further, the silicone-based pressure-sensitive adhesive may contain a reaction catalyst.

更に、 シリコーン系粘着剤は、 必要に応じて、 公知のシリコーン系粘着剤 に含まれる各種添加剤を含んでいてもよい。 Furthermore, the silicone-based pressure-sensitive adhesive may optionally contain various additives contained in known silicone-based pressure-sensitive adhesives.

[0050] アクリル系粘着剤 [0050] Acrylic adhesive

本開示におけるアクリル系粘着剤は、 アクリルポリマーをべースポリマー とする粘着剤を意味する。 The acrylic pressure-sensitive adhesive in the present disclosure means a pressure-sensitive adhesive using an acrylic polymer as a base polymer.

アクリル系粘着剤としては、 特に制限はなく、 公知のアクリル系粘着剤が 用いられる。 The acrylic pressure-sensitive adhesive is not particularly limited, and known acrylic pressure-sensitive adhesives can be used.

アクリル系粘着剤に含まれるアクリルポリマーとしては、 具体的には、 ア クリル酸エステル化合物の単独重合体、 又はアクリル酸エステル化合物とそ の他の単量体との共重合体が挙げられる。 Specific examples of the acrylic polymer contained in the acrylic pressure-sensitive adhesive include a homopolymer of an acrylic acid ester compound or a copolymer of an acrylic acid ester compound and another monomer.

アクリル酸エステル化合物の例には、 メチル (メタ) アクリレート、 エチ ル (メタ) アクリレート、 プチル (メタ) アクリレート、 2—エチルへキシ ル (メタ) アクリレート、 ヒドロキシエチルメタクリレート、 ヒドロキシプ ロピルメタクリレート、 ジメチルアミノエチルメタクリレート、 グリシジル メタクリレート等が挙げられる。 その他の単量体の例には、 酢酸ビニル、 ( メタ) アクリロニトリル、 (メタ) アクリルアミ ド、 スチレン、 メタクリル 酸、 アクリル酸、 イタコン酸、 メチロールアクリルアミ ド、 無水マレイン酸 等が挙げられる。 Examples of acrylic acid ester compounds include methyl (meth)acrylate, ethyl (meth)acrylate, butyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, hydroxyethyl methacrylate, hydroxypropyl methacrylate, dimethyl. Aminoethyl methacrylate, glycidyl methacrylate and the like can be mentioned. Examples of other monomers include vinyl acetate, (meth)acrylonitrile, (meth)acrylic amide, styrene, methacrylic acid, acrylic acid, itaconic acid, methylol acrylic amide, maleic anhydride and the like.

アクリルポリマーは架橋構造を有していてもよい。 The acrylic polymer may have a crosslinked structure.

[0051 ] アクリル系粘着剤は、 粘着性を高める観点から、 アクリルポリマーの他に 、 粘着性付与剤を含んでいてもよい。 [0051] The acrylic pressure-sensitive adhesive may contain a tackifier in addition to the acrylic polymer from the viewpoint of enhancing the tackiness.

粘着性付与剤としては、 ロジン系粘着性付与樹脂、 テルペン系粘着性付与 樹脂、 炭化水素系粘着性付与樹脂、 エポキシ系粘着性付与樹脂、 ポリアミ ド \¥0 2020/175681 16 卩(:171? 2020 /008363 Examples of tackifiers include rosin-based tackifier resins, terpene-based tackifier resins, hydrocarbon-based tackifier resins, epoxy-based tackifier resins, and polyamides. \¥0 2020/175681 16 卩 (: 171? 2020 /008363

系粘着性付与樹脂、 エラストマー系粘着性付与樹脂、 フエノール系粘着性付 与樹脂、 ケトン系粘着性付与樹脂等が挙げられる。 Examples of the tackifying resin include an elastomer-based tackifying resin, an elastomer-based tackifying resin, a phenol-based tackifying resin, and a ketone-based tackifying resin.

ァクリル系粘着剤は、 ァクリルポリマー及び粘着性付与剤の他に、 必要に 応じて、 公知のアクリル系粘着剤に含まれる各種添加剤を含んでいてもよい The acrylate-based pressure-sensitive adhesive may contain, in addition to the acrylate polymer and the tackifier, various additives contained in known acrylic-based pressure-sensitive adhesives, if necessary.

[0052] - ゴム系粘着剤 [0052]-Rubber adhesive

本開示におけるゴム系粘着剤は、 ゴムをベースポリマーとする粘着剤を意 味する。 The rubber-based pressure-sensitive adhesive in the present disclosure means a pressure-sensitive adhesive having rubber as a base polymer.

ゴムは、 特に制限されず、 天然ゴム (変性天然ゴムを含む) であってもよ いし、 合成ゴムであってもよい。 The rubber is not particularly limited, and may be natural rubber (including modified natural rubber) or synthetic rubber.

合成ゴムとしては、 巳 型又は 巳型のブロック共重合体 ( は熱可塑 性ブロックを示し、 巳はラバーブロックを示す。 スチレンーイソプレンース チレン共重合体 (3 1 3) 、 スチレンーブタジエンースチレン共重合体 (3 6 3) 等が挙げられる) が挙げられる。 ゴムは、 天然ゴムと合成ゴムとを組 み合わせたものであってもよい。 As the synthetic rubber, a type or a type block copolymer (is a thermoplastic block, and a type is a rubber block. Styrene-isoprene styrene copolymer (3 1 3), styrene-butadiene Examples thereof include styrene copolymers (363) and the like. The rubber may be a combination of natural rubber and synthetic rubber.

[0053] ゴム系粘着剤は、 粘着性を高める観点から、 ゴムの他に、 粘着性付与剤を 含んでいてもよい。 [0053] The rubber-based pressure-sensitive adhesive may contain a tackifier in addition to the rubber from the viewpoint of enhancing the tackiness.

粘着性付与剤としては、 ァクリル系粘着剤に用いられる各種の粘着性付与 樹脂が挙げられる。 Examples of the tackifier include various tackifier resins used for acrylate-based tackifiers.

ゴム系粘着剤は、 ゴム及び粘着性付与剤の他に、 必要に応じて、 公知のゴ ム系粘着剤に含まれる各種添加剤を含んでいてもよい。 The rubber-based pressure-sensitive adhesive may contain, in addition to the rubber and the tackifier, various additives contained in known rubber-based pressure-sensitive adhesives, if necessary.

[0054] (その他の成分) [0054] (Other ingredients)

第 2層は、 粘着剤に加えて、 その他の成分を含んでいてもよい。 その他の成分としては、 皮膚貼付け用積層体の用途に応じて、 適宜、 決定 されればよい。 The second layer may contain other components in addition to the adhesive. Other components may be appropriately determined depending on the use of the skin patch laminate.

例えば、 皮膚貼付け用積層体が、 経皮製剤として用いられる場合、 第 2層 は、 薬剤及び薬剤を保持及び放出するための添加剤を含有することが好まし い。 \¥0 2020/175681 17 卩(:17 2020 /008363 For example, when the skin patch laminate is used as a transdermal preparation, the second layer preferably contains a drug and an additive for retaining and releasing the drug. \¥0 2020/175681 17 卩(: 17 2020/008363

薬剤としては、 経皮製剤に適用しうる公知の薬剤が用いられる。 また、 薬 剤を保持及び放出するための添加剤としては、 使用実績の観点から、 例えば 、 乳酸、 グリコール酸、 ステアリン酸、 オレイン酸、 ミリスチン酸イソプロ ピル、 !_ _メントール、 エタノール、 プロピレングリコール等が挙げられる As the drug, a known drug applicable to transdermal preparations is used. In addition, as an additive for holding and releasing the drug, from the viewpoint of actual use, for example, lactic acid, glycolic acid, stearic acid, oleic acid, isopropyl myristate,! _ _Menthol, ethanol, propylene glycol, etc.

[0055] 第 2層の厚みとしては、 皮膚への粘着性が発現する観点から、 5 〜 3 [0055] The thickness of the second layer is 5 to 3 from the viewpoint of exhibiting adhesion to the skin.

0 0 〇!が好ましく、 5 〇!〜 1 5 0 〇!がより好ましく、 5 〇!〜 1 0 0 以下が更に好ましい。 0!! is preferred, 50!! to 1500! is more preferred, and 50! to 1000 or less is even more preferred.

[0056] [第 1支持体及び第 2支持体] [0056] [First support and second support]

本開示の積層体は、 第 1層の第 2層と接する面とは反対の面側に接する第 1支持体と、 第 2層の第 1層と接する面とは反対の面側に接する第 2支持体 と、 を有していてもよい。 The laminate of the present disclosure includes a first support member that contacts the surface of the first layer opposite to the surface that contacts the second layer, and a first support member that contacts the surface of the second layer opposite to the surface that contacts the first layer. Two supports may be included.

第 1支持体及び第 2支持体は、 皮膚への貼付け時には剥離される仮支持体 である。 The first support and the second support are temporary supports that are peeled off when attached to the skin.

[0057] 第 1支持体及び第 2支持体として特に制限はなく、 樹脂フィルムが用いら れることが好ましい。 [0057] The first support and the second support are not particularly limited, and a resin film is preferably used.

また、 第 1支持体と第 2支持体とは同じであってもよいし、 異なっていて もよい。 Further, the first support and the second support may be the same or different.

樹脂フイルムとしては、 ポリエステル (例えば、 ポリエチレンテレフタレ —卜 ( 巳丁) 、 ポリエチレンナフタレート、 ポリプチレンテレフタレート 等) 、 ポリウレタン、 シリコーン、 ポリオレフイン (例えば、 ポリエチレン 、 ポリプロピレン等) 、 ポリスチレン等の樹脂フィルムが挙げられる。 中でも、 樹脂フイルムとしては、 口ールトウロール方式への適用時のハン ドリング性に優れる観点、 及び、 熱安定性の観点から、 ポリエチレンテレフ タレート ( 巳丁) が好ましい。 Examples of the resin film include resin films such as polyester (for example, polyethylene terephthalate (polyester), polyethylene naphthalate, polypropylene terephthalate, etc.), polyurethane, silicone, polyolefin (for example, polyethylene, polypropylene, etc.), polystyrene, etc. To be Among them, as the resin film, polyethylene terephthalate (Mending) is preferable from the viewpoint of excellent handling properties when applied to the mouth tow roll method and from the viewpoint of thermal stability.

[0058] 第 1支持体及び第 2支持体の厚みは、 特に制限はないが、 口ールトウロー ル方式への適用時のハンドリング性に優れる点、 及び、 剥離しやすさの観点 から、 1 0 〇!〜 1 0 0 が好ましく、 2 0 111 ~ 1 0 0 がより好ま \¥0 2020/175681 18 卩(:171? 2020 /008363 [0058] The thickness of the first support and the second support is not particularly limited, but from the viewpoint of excellent handleability when applied to the mouth-to-roll method and the ease of peeling, 100 !~100 is preferred, 2011~100 is more preferred \¥0 2020/175681 18 卩 (: 171? 2020 /008363

しく、 5 0 〇!〜 1 0 0 01が更に好ましい。 However, 500!~100100 is more preferable.

[0059] 第 1支持体及び第 2支持体は、 上記の通り、 皮膚への貼付け時には剥離さ れるため、 第 1支持体と第 1層との間、 及び第 2支持体と第 2層との間に剥 離性を有することが好ましい。 [0059] As described above, the first support and the second support are peeled off at the time of application to the skin, and therefore, between the first support and the first layer, and between the second support and the second layer. It is preferable to have a peeling property between them.

そのため、 第 1支持体の第 1層側及び第 2支持体の第 2層側の少なくとも —方は、 必要に応じて、 シリコーン層を有する、 又は、 シリコーンにより表 面処理されていることが好ましい。 Therefore, it is preferable that at least one of the first support side of the first support and the second support side of the second support has a silicone layer or is surface-treated with silicone, if necessary. ..

シリコーン層は、 シリコーンポリマーを含む層であればよく、 分子内にフ ッ素原子又はフッ素原子を含む置換基を有するフロロシリコーンポリマーを 含む層 (以下、 フロロシリコーン層ともいう) であることが好ましい。 フロロシリコーンポリマー中のフッ素原子量を調整することで、 第 1層及 び第 2層との剥離性を制御することができる。 The silicone layer may be a layer containing a silicone polymer, and is preferably a layer containing a fluorosilicone polymer having a substituent containing a fluorine atom or a fluorine atom in the molecule (hereinafter, also referred to as a fluorosilicone layer). .. By adjusting the amount of fluorine atoms in the fluorosilicone polymer, the peelability from the first layer and the second layer can be controlled.

また、 シリコーンによる表面処理には、 例えば、 溶液の塗布乾燥法を用い た液相製膜等を用いた表面処理が挙げられる。 The surface treatment with silicone includes, for example, surface treatment using liquid phase film formation using a solution coating/drying method.

また、 第 1支持体及び第 2支持体に剥離性を付与する方法としては、 例え ば、 フッ素含有化合物による表面処理を用いてもよい。 具体的には、 フッ素 含有化合物による表面処理には、 スパッタリング、 蒸着等の気相製膜等を用 いた表面処理が適用される。 As a method of imparting releasability to the first support and the second support, surface treatment with a fluorine-containing compound may be used, for example. Specifically, for the surface treatment with a fluorine-containing compound, surface treatment using vapor phase film formation such as sputtering or vapor deposition is applied.

第 1支持体及び第 2支持体としては、 市販品を用いてもよい。 市販品としては、 例えば、 フジコー社製のシリコーン層を片面又は両面に 備える剥離フィルム (例えば、 フロロシリコーン剥離フィルム等) が挙げら れる。 As the first support and the second support, commercially available products may be used. Examples of commercially available products include a release film (for example, a fluorosilicone release film, etc.) having a silicone layer manufactured by Fujiko Co., Ltd. on one side or both sides.

[0060] <皮膚貼付け用積層体の製造方法> <Method for producing laminate for skin application>

本開示の皮膚貼付け用積層体は、 以下の方法 (即ち、 本開示の皮膚貼付け 用積層体の製造方法) で製造されることが好ましい。 The skin patch laminate of the present disclosure is preferably produced by the following method (that is, the method for producing the skin patch laminate of the present disclosure).

即ち、 本開示の皮膚貼付け用積層体の製造方法は、 シリコーンエラストマ 一を含む第 1層を形成する工程八と、 粘着性を有する第 2層を形成する工程 巳と、 を有し、 第 1層と第 2層との積層物の 4 0 %伸長時の引張応力が〇. \¥02020/175681 19 卩(:171?2020/008363

Figure imgf000020_0001
以下である、 皮膚貼付け用積層 体の製造方法 (以下、 積層体の製造方法ともいう) である。 That is, the method for producing a skin patch laminate of the present disclosure includes a step 8 of forming a first layer containing a silicone elastomer, and a step of forming a second layer having adhesiveness. The tensile stress at 40% elongation of the laminate of the first layer and the second layer is ◯. \\02020/175681 19
Figure imgf000020_0001
The following is a method for producing a laminate for skin application (hereinafter, also referred to as a method for producing a laminate).

[0061 ] [工程八] [0061] [Step 8]

工程八では、 シリコーンエラストマーを含む第 1層を形成する。 第 1層を 形成する方法に制限はないが、 以下の工程であることが好ましい。 In step 8, a first layer containing a silicone elastomer is formed. The method for forming the first layer is not limited, but the following steps are preferable.

即ち、 工程八は、 第 1支持体上に、 架橋性基を有するシリコーンポリマー 、 架橋剤、 及び溶剤を含む塗布液 (以下、 塗布液!- 1 ともいう) を塗布及び 乾燥させて、 第 1層を形成する工程八であることが好ましい。 That is, in the step 8, a coating liquid (hereinafter, also referred to as coating liquid!-1) containing a silicone polymer having a crosslinkable group, a crosslinking agent, and a solvent is applied onto the first support and dried to form a first coating. The eighth step of forming a layer is preferable.

また、 工程八は、 第 1支持体上に、 架橋性基を有するシリコーンポリマー 、 架橋剤、 シリカ粒子、 及びシリコーン系溶剤を含む塗布液 (以下、 塗布液 1- 2ともいう) を塗布及び乾燥させて、 第 1層を形成する工程であることが 好ましい。 Step 8 is to coat and dry a coating solution (hereinafter also referred to as coating solution 1-2) containing a silicone polymer having a crosslinkable group, a crosslinking agent, silica particles, and a silicone solvent on the first support. Then, the step of forming the first layer is preferable.

つまり、 工程 は、 第 1支持体上に塗布液 !_ 1又は !_ 2を塗布及び乾燥さ せて形成されることが好ましい。 That is, it is preferable that the step is formed by applying and drying the coating liquid !_ 1 or !_ 2 on the first support.

なお、 本開示の積層体の製造方法は、 連続搬送される第 1支持体を用い、 口ールトゥロール方式にて工程 及び後述する工程巳が行われることが好ま しい。 In addition, in the method for manufacturing a laminated body of the present disclosure, it is preferable that the first support that is continuously conveyed is used and that the steps and the steps described below are performed by a mouth-to-roll method.

[0062] (塗布液 !_ 1及び !_ 2) [0062] (Coating liquids !_ 1 and !_ 2)

塗布液!- 1及び 1_ 2に含まれる、 架橋性基を有するシリコーンポリマー、 架橋剤、 及びシリカ粒子としては、 いずれも、 第 1層の欄で説明したこれら の成分が挙げられ、 好ましい態様も同様である。 Coating liquid! Examples of the silicone polymer having a crosslinkable group, the crosslinker, and the silica particles contained in 1 and 1_2 include the components described in the section of the first layer, and the preferred embodiments are also the same. ..

塗布液!- 1及び !_ 2に含まれる溶剤としては、 架橋性基を有するシリコー ンポリマーの良溶媒であることが好ましい。 架橋性基を有するシリコーンポ リマーの良溶媒としては、 シリコーン系溶剤の他、 酢酸エチル、 ヘプタン、 テトラヒドロフラン、 メチルエチルケトン等が挙げられる。 塗布液 1_ 1及び 1- 2に含まれる溶剤は、 1種単独で使用してもよいし、 2種以上を混合して 用いてもよい。 中でも、 塗布液 !_ 1及び !_ 2に含まれる溶剤としては、 シリ コーン系溶剤が好ましい。 \¥0 2020/175681 20 卩(:171? 2020 /008363 Coating liquid! -The solvent contained in 1 and !_ 2 is preferably a good solvent for a silicone polymer having a crosslinkable group. Examples of the good solvent for the silicone polymer having a crosslinkable group include silicone solvents, ethyl acetate, heptane, tetrahydrofuran, methyl ethyl ketone, and the like. The solvents contained in the coating liquids 1_1 and 1-2 may be used alone or in combination of two or more. Above all, a silicone-based solvent is preferable as the solvent contained in the coating liquids !_ 1 and !_ 2. \¥0 2020/175681 20 卩 (: 171? 2020 /008363

塗布液!- 1及び塗布液 1_ 2に含まれるシリコーン系溶剤としては、 へキサ メチルシクロトリシロキサン、 オクタメチルシクロテトラシロキサン、 デカ メチルシクロテトラシロキサン (シクロペンタシロキサンともいう) 等の環 状シロキサンが好ましい。 Coating liquid! -1 and the silicone solvent contained in the coating liquid 1_2 are preferably cyclic siloxanes such as hexamethylcyclotrisiloxane, octamethylcyclotetrasiloxane, and decamethylcyclotetrasiloxane (also referred to as cyclopentasiloxane).

塗布液 !_ 1及び塗布液 !_ 2は、 それぞれ、 第 1層の欄で説明したその他の 成分を含んでいてもよい。 Coating liquid !_ 1 and coating liquid !_ 2 may each contain the other components described in the section of the first layer.

更に、 塗布液 1- 1及び塗布液 !_ 2は、 シリコーンエラストマーを得る反応 に用いられる、 反応遅延剤、 反応禁止剤等を含んでいてもよい。 Furthermore, the coating liquid 1-1 and the coating liquid !_2 may contain a reaction retarder, a reaction inhibitor, etc. used in the reaction for obtaining the silicone elastomer.

反応遅延剤又は反応禁止剤としては、 第 1層中に残存しにくい成分である ことが好ましく、 揮発性 (例えば、 沸点が 1 0 0 °〇以下) の化合物であるこ とが好ましく、 塗布液 !_ 1及び塗布液 !_ 2に含まれる溶剤 (例えば、 環状シ ロキサン等のシリコーン系溶剤) の沸点よりも低い沸点を有する化合物であ ることがより好ましい。 反応遅延剤又は反応禁止剤としては具体的には、 例 えば、 アセチレンアルコール類 (例えば、 2 -メチルー 3 -ブチンー 2 -才 —ル、 環状シロキサン類 (例えば、 テトラビニルテトラメチルシクロテトラ シロキサン) 等が挙げられる。 The reaction retarder or reaction inhibitor is preferably a component that does not easily remain in the first layer, and is preferably a volatile (for example, boiling point is 100 ° C. or less) compound. It is more preferable that the compound has a boiling point lower than that of the solvent (eg, silicone-based solvent such as cyclic siloxane) contained in _ 1 and the coating liquid !_ 2. Specific examples of the reaction retarder or reaction inhibitor include, for example, acetylene alcohols (eg, 2-methyl-3-butyne-2-yl), cyclic siloxanes (eg, tetravinyltetramethylcyclotetrasiloxane), etc. Is mentioned.

[0063] 塗布液 !_ 1及び塗布液 !_ 2中の固形分量 (溶剤を除く成分の総計) として は、 塗布液の塗布しやすさ、 塗布液の送液及び濾過のしやすさ等に応じて決 定されればよく、 1 0質量%〜 7 0質量%が好ましく、 1 5質量%〜 6 5質 量%がより好ましく、 2 0質量%〜 5 0質量%が更に好ましい。 [0063] The solid content (total amount of components excluding the solvent) in the coating liquid !_ 1 and the coating liquid !_ 2 depends on the ease of applying the coating liquid, the ease of feeding and filtering the coating liquid, and the like. It may be determined according to the conditions, preferably 10% by mass to 70% by mass, more preferably 15% by mass to 65% by mass, further preferably 20% by mass to 50% by mass.

[0064] (第 1支持体) [0064] (First support)

工程八に用いられる第 1支持体は、 既述の第 1支持体が挙げられ、 好まし い態様も同様である。 Examples of the first support used in step 8 include the above-mentioned first support, and the preferred embodiments are also the same.

即ち、 工程八に用いられる第 1支持体は、 第 1層との剥離性を高める観点 から、 第 1層側の面にシリコーン層を有することが好ましい。 That is, the first support used in step 8 preferably has a silicone layer on the surface on the first layer side from the viewpoint of enhancing the releasability from the first layer.

[0065] (塗布及び乾燥) (Coating and drying)

塗布液 !_ 1又は塗布液!- 2の塗布方法としては、 公知の塗布方法を適用す ることができる。 \¥0 2020/175681 21 卩(:171? 2020 /008363 Coating liquid !_ 1 or coating liquid! As the coating method of -2, a known coating method can be applied. \¥0 2020/175681 21 卩 (: 171? 2020 /008363

塗布方法として具体的には、 力ーテンコーティング法、 ディップコーティ ング法、 スピンコーティング法、 印刷コーティング法、 スプレーコーティン グ法、 スロッ トコーティング法、 口ールコーティング法、 スライ ドコーティ ング法、 ブレードコーティング法、 グラビアコーティング法、 ワイヤーバー 法等が挙げられる。 Specific coating methods include force-ten coating method, dip coating method, spin coating method, print coating method, spray coating method, slot coating method, mouth coating method, slide coating method, blade coating method. Method, gravure coating method, wire bar method and the like.

中でも、 特に、 連続搬送される第 1支持体を用い、 口ールトゥロール方式 にて工程八を行う場合、 塗布方法としては、 スロッ トコーティング法が好ま しい。 Above all, the slot coating method is preferable as the coating method when the step 8 is performed by the mouth toe roll method using the first support which is continuously conveyed.

[0066] 工程八に用いられる乾燥方法としては、 公知の乾燥方法を適用することが できる。 [0066] As the drying method used in Step 8, a known drying method can be applied.

乾燥方法としては、 具体的には、 オーブン、 温風機、 赤外線 (丨 [¾) ヒー 夕一等を用いる方法が挙げられる。 温風機による乾燥においては、 第 1支持 体の塗布液が塗布された面とは反対側の面から温風を当ててもよい。 Specific examples of the drying method include a method using an oven, a warm air blower, an infrared ray (see [¾] heater), and the like. In drying with a warm air blower, warm air may be applied from the surface of the first support opposite to the surface coated with the coating liquid.

乾燥条件としては、 例えば、 7 0 °〇 ~ 1 1 0 °〇の範囲で、 1 0分〜 3 0分 間が好ましい。 The drying conditions, e.g., in the range of 7 0 ° 〇 ~ 1 1 0 ° 〇, between 1 0 minutes to 3 0 minutes is preferred.

また、 必要に応じて、 乾燥後の第 1層には、 塗布液 !_ 1及び塗布液 !_ 2中 に含まれる反応遅延剤、 反応禁止剤等を除去するための加熱を行ってもよい 。 この加熱の際の加熱条件は、 例えば、 7 0 °〇~ 1 5 0 °〇の範囲で、 3 0分 〜 9 0分間が好ましい。 If necessary, the first layer after drying may be heated to remove the reaction delay agent, reaction inhibitor, etc. contained in the coating liquid !_ 1 and the coating liquid !_2. .. Heating conditions during this heating may, for example, in the range of 7 0 ° 〇 ~ 1 5 0 ° 〇, preferably 3 0 minutes to 9 0 minutes.

[0067] [工程巳] [0067] [Processing method]

工程巳では、 粘着性を有する第 2層を形成する。 In the process step, the second layer having adhesiveness is formed.

工程巳は、 例えば、 後述する第 2支持体上に第 2層を形成する工程であっ てもよいし、 工程八にて形成された第 1層上に第 2層を形成する工程であっ てもよい。 The process step may be, for example, a step of forming the second layer on the second support described later, or a step of forming the second layer on the first layer formed in step 8. Good.

工程巳が、 第 2支持体上に第 2層を形成する工程である場合、 形成された 第 2層上に工程八にて第 1層を形成し、 本開示の積層体を製造してもよい。 また、 工程巳が、 第 2支持体上に第 2層を形成する工程である場合、 形成さ れた第 2層と工程八にて第 1支持体上に形成された第 1層とを貼り合わせる \¥0 2020/175681 22 卩(:171? 2020 /008363 When the process step is a process of forming the second layer on the second support, the first layer is formed on the formed second layer in step 8, and the laminated body of the present disclosure is manufactured. Good. In addition, when the process step is a process of forming the second layer on the second support, the second layer formed and the first layer formed on the first support in step 8 are attached. match \¥0 2020/175681 22 卩 (: 171? 2020 /008363

ことで、 本開示の積層体を製造してもよい。 Thus, the laminated body of the present disclosure may be manufactured.

なお、 本開示の積層体の製造方法では、 製造適性の観点から、 工程巳は、 工程八にて形成された第 1層上に第 2層を形成する工程であることが好まし い。 In the method for manufacturing a laminated body of the present disclosure, from the viewpoint of manufacturing suitability, it is preferable that the process step is a step of forming the second layer on the first layer formed in step 8.

更に言えば、 工程巳は、 第 1層上に、 粘着剤を含む塗布液 (以下、 塗布液 1- 3ともいう) を塗布及び乾燥させて、 第 2層を形成する工程であることが 好ましい。 More specifically, the process step is preferably a process of forming a second layer by applying a coating liquid containing an adhesive (hereinafter, also referred to as coating liquid 1-3) on the first layer and drying the coating liquid. ..

[0068] (塗布液 1_ 3) [0068] (Coating liquid 1_3)

塗布液 1_ 3に含まれる粘着剤としては、 第 2層の欄で説明した粘着剤が挙 げられ、 好ましい態様も同様である。 Examples of the adhesive contained in the coating liquids 1_3 include the adhesives described in the section of the second layer, and the preferred embodiments are also the same.

塗布液 1_ 3は、 粘着剤と共に溶剤を含むことが好ましい。 The coating liquids 1_3 preferably contain a solvent together with the adhesive.

塗布液 1_ 3に含まれる溶剤としては、 粘着剤中のベースポリマーの良溶媒 であることが好ましい。 例えば、 1_ 3に含まれる粘着剤がシリコーン系粘着 剤の場合、 溶剤としてはシリコーン系溶剤を用いることが好ましい。 シリコ —ン系溶剤としては、 塗布液 !- 1及び塗布液 !_ 2に含まれるシリコーン系溶 剤が挙げられる。 The solvent contained in the coating liquids 1_3 is preferably a good solvent for the base polymer in the adhesive. For example, when the adhesive contained in 1_3 is a silicone-based adhesive, it is preferable to use a silicone-based solvent as the solvent. Examples of silicone-based solvents include the silicone-based solvents contained in coating liquid !-1 and coating liquid !_2.

[0069] 塗布液 1- 3中の固形分量 (溶剤を除く成分の総計) としては、 塗布液の塗 布しやすさ、 塗布液の送液及び濾過のしやすさ等に応じて決定されればよく 、 1 〇質量%〜 6 5質量%が好ましく、 1 5質量%〜 6 0質量%がより好ま しく、 2 5質量%〜 5 5質量%が更に好ましい。 [0069] The solid content (total amount of components excluding the solvent) in the coating liquid 1-3 is determined according to the ease of applying the coating liquid, the ease with which the coating liquid is delivered and filtered. Of course, 10 mass% to 65 mass% is preferable, 15 mass% to 60 mass% is more preferable, and 25 mass% to 55 mass% is further preferable.

[0070] (塗布及び乾燥) [0070] (Coating and drying)

工程巳に用いられる塗布方法及び乾燥方法としては、 工程 における塗布 方法及び乾燥方法が挙げられ、 好ましい態様も同様である。 Examples of the coating method and the drying method used in the process step include the coating method and the drying method in the step, and preferred embodiments are also the same.

[0071 ] [工程 1及び工程八 2 ] [0071] [Step 1 and Step 8 2]

本開示の積層体の製造方法は、 製造効率等の観点から、 搬送される第 1支 持体を用い、 口ールトゥロール方式にて工程 及び工程巳が行われることが 好ましい。 From the viewpoint of production efficiency and the like, in the method for producing a layered product of the present disclosure, it is preferable that the first support to be conveyed be used to carry out the steps and steps in a mouth-to-roll method.

そこで、 第 1層の保護のため、 工程八と工程巳との間に、 以下に示す工程 \¥0 2020/175681 23 卩(:171? 2020 /008363 Therefore, in order to protect the first layer, the following steps should be performed between step 8 and step \¥0 2020/175681 23 卩 (: 171? 2020 /008363

八 1及び工程八 2を行うことが好ましい。 It is preferable to carry out step 81 and step 82.

例えば、 連続搬送される第 1支持体を用い、 口ールトゥロール方式にてエ 程八を行う場合、 工程八後であって工程巳前に、 第 1層を有する第 1支持体 を巻き取る場合がある。 この巻き取りにて第 1層が第 1支持体の裏面 (即ち 、 第 1層が形成される面とは反対の面) に接することで、 第 1層に傷ができ てしまうことがある。 そのため、 工程八と工程巳との間では、 以下に示すエ 程八 1及び工程八 2を行い、 第 1層の表面を保護することが好ましい。 For example, in the case where the process is carried out by the mouth-to-roll method using the continuously transported first support, the first support having the first layer may be wound after the process 8 but before the process. is there. When the first layer contacts the back surface of the first support (that is, the surface opposite to the surface on which the first layer is formed) by this winding, the first layer may be damaged. Therefore, it is preferable to protect the surface of the first layer by performing the following steps 81 and 82 between step 8 and step.

[0072] (工程八 1) [0072] (Process eight 1)

工程八 1では、 工程八にて形成された第 1層の表面に保護フィルムを貼り 合わせる。 In step 81, a protective film is attached to the surface of the first layer formed in step 8.

保護フィルムとしては、 少なくとも、 第 1層と接する面に第 1層に対する 剥離性を有することが好ましい。 As the protective film, it is preferable that at least the surface in contact with the first layer has releasability from the first layer.

保護フィルムとして具体的には、 巳 八 (エチレンー酢酸ビニル共重合樹 脂) フィルム (市販品であれば、 例えば、 (株) サンエー化研社の 八〇 3 等の 八〇シリーズ) 、 ポリオレフィンフィルム (市販品であれば、 例えば 、 東レ (株) の表面保護フィルム、 トレテック (登録商標) シリーズ) 等が 挙げられる。 Specific examples of the protective film include a Mitsuhachi (ethylene-vinyl acetate copolymer resin) film (commercially available products include, for example, 803 series of Sanae Kaken Co., Ltd. 80 series), polyolefin film ( Examples of commercially available products include surface protective films of Toray Industries, Inc., Tretec (registered trademark) series, and the like.

保護フィルムの貼り合わせ方法としては、 口ールラミネート法等の公知の フィルムの貼り合わせ方法を適用することができる。 As a method for laminating the protective film, a known film laminating method such as a mouth laminating method can be applied.

[0073] (工程八 2) (Step 8 2)

工程八 2では、 工程八 1で貼り合わされた保護フィルムを第 1層の表面か ら剥離する。 In step 82, the protective film attached in step 81 is peeled from the surface of the first layer.

保護フィルムの剥離方法としては、 公知のフィルムの剥離方法又は除去方 法を適用することができる。 As a method for peeling the protective film, a known method for peeling or removing the film can be applied.

[0074] [工程八 3 ] [0074] [Step 8 3]

第 1層と第 2層との密着性を高めるため、 工程八と工程巳との間に、 工程 八にて形成された第 1層の表面を親水化処理する工程 3を行うことが好ま しい。 \¥0 2020/175681 24 卩(:171? 2020 /008363 In order to enhance the adhesion between the first layer and the second layer, it is preferable to perform step 3 of hydrophilicizing the surface of the first layer formed in step 8 between step 8 and step. .. \¥0 2020/175681 24 卩 (: 171? 2020 /008363

工程八 3で行われる第 1層の表面に対する親水化処理は、 コロナ処理又は プラズマ処理が挙げられ、 特に、 生産性の観点、 及び、 装置メンテナンスの 観点から、 コロナ処理であることが好ましい。 Examples of the hydrophilic treatment for the surface of the first layer performed in step 83 include corona treatment and plasma treatment. Particularly, from the viewpoint of productivity and the viewpoint of equipment maintenance, corona treatment is preferable.

コロナ処理に用いられるコロナ処理装置としては、 特に制限はなく、 例え ば、 vetaphone社製、

Figure imgf000025_0001
社製等の口ールトゥロール方式で処理可能なコロ ナ処理装置の他、 春日電機 (株) の丁巳(3 _ 4 乂が挙げられる。 The corona treatment device used for corona treatment is not particularly limited, for example, vetaphone,
Figure imgf000025_0001
In addition to the corona treatment equipment that can be processed by the mouth-to-roll method such as manufactured by the company, there is a Tatsumi (3 _ 4) manufactured by Kasuga Electric Co., Ltd.

また、 親水化処理の条件としては、 例えば、 以下に示す接触角となるよう に適宜決定すればよい。 The conditions for the hydrophilization treatment may be appropriately determined, for example, so that the contact angle is as shown below.

[0075] 工程八 3にて親水化処理された第 1層の表面は、 1\1 -メチルー 2 -ピロリ ドン (以下、

Figure imgf000025_0002
ともいう) との接触角が 6 0度以下であることが好まし く、 5 0度以下であることがより好ましい。 [0075] The surface of the first layer hydrophilized in step 83 was 1\1-methyl-2-pyrrolidone (hereinafter,
Figure imgf000025_0002
Also referred to as a contact angle) is preferably 60 degrees or less, and more preferably 50 degrees or less.

第 1層の表面と 1\/1 ?との接触角の測定には、 接触角計 (例えば、 協和界 面科学 (株) の口1\/1〇_ 7 0 1) が用いられる。 また、 接触角の測定は、 2 5 °◦で行う。 To measure the contact angle between the surface of the first layer and 1\/1?, a contact angle meter (for example, mouth 1\/1○_7101 of Kyowa Surface Science Co., Ltd.) is used. The contact angle shall be measured at 25°°.

[0076] [工程〇] [0076] [Process 〇]

第 2層の保護のため、 工程巳にて第 2層が形成された後、 第 2層上に第 2 支持体を貼り合わせる工程<3を有することが好ましい。 In order to protect the second layer, it is preferable to have a step <3 of laminating the second support on the second layer after the second layer is formed in the step.

第 2支持体の貼り合わせ方法としては、 公知のフィルムの貼り合わせ方法 を適用することができる。 As a method for laminating the second support, a known film laminating method can be applied.

[0077] (第 2支持体) [0077] (Second support)

工程〇に用いられる第 2支持体は、 既述の第 2支持体が挙げられ、 好まし い態様も同様である。 Examples of the second support used in the step ◯ include the above-mentioned second support, and the preferred embodiments are also the same.

即ち、 工程〇に用いられる第 2支持体は、 第 2層との剥離性を高める観点 から、 第 2層側の面にシリコーン層を有することが好ましい。 That is, it is preferable that the second support used in the step ◯ has a silicone layer on the surface on the second layer side from the viewpoint of enhancing the releasability from the second layer.

[0078] 以上のようにして、 本開示の積層体を製造することができる。 The laminate of the present disclosure can be manufactured as described above.

[0079] <積層体の用途> [0079] <Use of laminated body>

本開示の積層体の用途は、 適用対象者の皮膚に貼付ける用途であれば、 特 に制限はない。 \¥0 2020/175681 25 卩(:171? 2020 /008363 The application of the laminate of the present disclosure is not particularly limited as long as it is applied to the skin of the application target person. \¥0 2020/175681 25 卩 (: 171? 2020 /008363

特に、 本開示の積層体は、 違和感なく貼付けられ、 皮膚の動きに追従し、 且つ、 皮膚からの放出される水蒸気の透過性に優れるため、 長時間貼付ける 用途であることが、 本開示の積層体の効果が発揮されやすい。 In particular, since the laminate of the present disclosure is applied without feeling uncomfortable, follows the movement of the skin, and has excellent permeability of water vapor released from the skin, it is a use for a long time of application of the present disclosure. The effect of the laminated body is easily exhibited.

具体的には、 本開示の積層体は、 生体モニタリングデバイス、 表示素子、 創傷被覆材、 経皮製剤、 又は化粧品に用いることが好ましい。 Specifically, the laminate of the present disclosure is preferably used for a living body monitoring device, a display element, a wound dressing material, a transdermal preparation, or a cosmetic product.

生体モニタリングデバイスとしては、 適用対象者の皮膚に貼付けることで 、 適用対象者の生体情報 (例えば、 皮膚の温度、 血圧、 血中酸素濃度、 心拍 数、 脈拍数、 紫外線量、 活動量、 心電モニター、 汗の〇 !·!等) を測定するウ ェアラブルデバイスが挙げられる。 本開示の積層体は、 生体モニタリングデ バイスの一部である皮膚への貼付け箇所に適用できる。 As a biological monitoring device, it can be attached to the skin of the target person to obtain biological information of the target person (for example, skin temperature, blood pressure, blood oxygen concentration, heart rate, pulse rate, UV dose, activity level, heart rate, heart rate). Examples include electric monitors, wearable devices that measure sweat (○!·!, etc.). The layered product of the present disclosure can be applied to a part to be attached to the skin that is a part of the biological monitoring device.

表示素子としては、 例えば、 表示機能 (例えば、 有機巳 1_ディスプレイ等 ) を有しており、 適用対象者の皮膚に貼付けて、 適用対象者の皮膚に貼付け ることで、 適用対象者の生体情報 (上記と同様のもの) 、 その他の情報 (例 えば、 モバイル端末の情報等) を表示するウェアラブルデバイスが挙げられ る。 本開示の積層体は、 表示素子の一部である皮膚への貼付け箇所に適用で きる。 The display element has, for example, a display function (for example, an organic semiconductor 1_display, etc.), and by sticking it on the skin of the person to whom it is applied, by sticking it on the skin of the person to whom it is applied, Examples include wearable devices that display information (the same as above) and other information (for example, mobile terminal information). The laminated body of the present disclosure can be applied to a part to be attached to the skin which is a part of the display element.

創傷被覆材としては、 ドレッシング材とも呼ばれており、 適用対象者の皮 膚に貼付けることで、 皮膚の創傷、 熱傷等を覆うために用いられる積層体で ある。 本開示の積層体は、 創傷被覆材そのものとして用いてもよいし、 創傷 被覆材の _部である皮膚への貼付け箇所に適用してもよい。 Wound dressings, also called dressings, are laminates that are used to cover skin wounds, burns, etc. by applying them to the skin of the person to whom they are applied. The laminate of the present disclosure may be used as a wound dressing itself, may be applied to the joining portion to the skin is a _ part of the wound dressing.

経皮製剤は、 適用対象者の皮膚に貼付けることで、 経皮製剤中に含まれる 薬剤を経皮吸収させるために用いられる積層体である。 本開示の積層体は、 第 2層中に薬剤を含ませて、 経皮製剤そのものとして用いることが好ましい 本開示に積層体は、 適用対象者の皮膚に貼付け、 例えば、 皮膚を美化する 化粧品として用いてもよい。 具体的には、 本開示の積層体は、 皮膚にある傷 、 シミ、 入れ墨等を隠す目的の化粧品として用いられてもよいし、 皮膚のし わを埋める又は伸ばす目的の化粧品として用いられてもよい。 [0080] <積層体の使用方法> The transdermal preparation is a laminate used for percutaneously absorbing the drug contained in the transdermal preparation by applying it to the skin of the application subject. The layered product of the present disclosure preferably contains a drug in the second layer and is used as a transdermal preparation itself. The layered product of the present disclosure is applied to the skin of an application target, for example, as a cosmetic to beautify the skin. You may use. Specifically, the laminate of the present disclosure may be used as a cosmetic for the purpose of concealing wounds, spots, tattoos, etc. on the skin, or as a cosmetic for the purpose of filling or extending wrinkles on the skin. Good. <How to use the laminate>

本開示の積層体は、 適用対象者の皮膚に貼付けて使用されるが、 その貼付 け箇所は、 特に制限はない。 また、 本開示の積層体は、 粘着性が発現できる 箇所であれば、 例えば、 爪など貼付けてもよいし、 皮膚と爪との両方に跨っ て貼付けてもよい。 The layered product of the present disclosure is used by being attached to the skin of the person to whom it is applied, but the place of attachment is not particularly limited. In addition, the laminate of the present disclosure may be attached, for example, a nail or the like, or may be attached across both the skin and the nail, as long as the adhesiveness can be exhibited.

特に、 本開示の積層体は、 違和感なく貼付けられ、 皮膚の動きに追従する ことから、 膝、 肘、 指等の関節部位へと貼付けることができる。 In particular, the laminate of the present disclosure can be applied to a joint site such as a knee, an elbow, or a finger, since it can be applied without a feeling of strangeness and follows the movement of the skin.

本開示の積層体は、 皮膚からの放出される水蒸気の透過性にも優れるため 、 貼付け時間が、 例えば、 48時間以上であってもよい。 Since the laminate of the present disclosure is excellent in the permeability of water vapor released from the skin, the application time may be, for example, 48 hours or more.

実施例 Example

[0081] 以下、 皮膚貼付け用積層体について、 実施例を挙げて詳細に説明する。 し かしながら、 本発明は以下の実施例に何ら限定されない。 [0081] Hereinafter, the laminate for skin application will be described in detail with reference to Examples. However, the present invention is not limited to the following examples.

[0082] [実施例 1〜 1 3及び比較例 3〜 4 ] [Examples 1 to 13 and Comparative Examples 3 to 4]

(第 1層の形成) (Formation of the first layer)

_塗布液の調製 _ _Preparation of coating liquid_

バイアルに、 シリカ粒子 (Alfa社製、 Si I icon(IV) oxide, amorphous fume d, surface treated, B ET法による比表面積: 205 m2/ g〜 245 m 2 /g, CAS 7631-86-9) 、 シクロペンタシロキサン (信越化学工業 (株) 製、 K F-995) 、 及び、 両主鎖末端にビニル基を有するポリジメチルシロキ サン (V— P DMSと略記、 Aldrich社製、 Poly(dimethylsi loxane), vinyl terminated, 重量平均分子量〜 25, 000、 粘度 850— 1 , 1 50 c S t) を入れて、 シリカ粒子の粉末が溶解するまで攪拌を行う。 The vial silica particles (Alfa Corp., Si I icon (IV) oxide , amorphous fume d, surface treated, the specific surface area by the B ET method: 205 m 2 / g~ 245 m 2 / g, CAS 7631-86-9 ), cyclopentasiloxane (manufactured by Shin-Etsu Chemical Co., Ltd., K F-995) loxane), vinyl terminated, weight average molecular weight ~ 25,000, viscosity 850-1 ,150 c St) and stir until the powder of silica particles dissolves.

シリカ粒子の粉末の溶解性を目視で確認した後、 金属触媒 (P t触媒と略 記、 白金 (〇) — 1 , 3—ジビニルー 1 , 1 , 3, 3—テトラメチルジシロ キサン錯体溶液 (Aldrich社製) ) を塗布液の総質量に対して 500 p p mと なる量で添加して、 30分間攪拌を行う。 After visually confirming the solubility of the silica particle powder, a metal catalyst (abbreviated as Pt catalyst, platinum (○) — 1,3-divinyl-1,1,1,3,3-tetramethyldisiloxane complex solution ( Aldrich))) is added in an amount of 500 ppm with respect to the total mass of the coating solution, and the mixture is stirred for 30 minutes.

次いで、 メチルヒドロシロキサンとジメチルシロキサンとの共重合体 (H — P D M Sと略記、 Aldrich社製、 Polv(dimethylsi loxane-co-methy [hydros i loxane), tr imethy Isi ly l terminated, 数平均分子量〜 1 3 , 000、 methy Ihydrosi loxane 3〜 4mol%) を添加し、 攪拌することで、 第 1層形成用の塗布 液とした。 Next, a copolymer of methylhydrosiloxane and dimethylsiloxane (abbreviated as H — PDMS, manufactured by Aldrich, Polv (dimethylsi loxane-co-methy [hydros i loxane), tr imethy isiily terminated, number average molecular weight ~ 13,000, methy Ihydrosi loxane 3 ~ 4mol%) was added and stirred to obtain a coating solution for forming the first layer.

なお、 第 1層形成用の塗布液中のシリカ粒子、 V—P DMS、 及び H— P D MSの含有量は、 下記表 1及び表 2にまとめた。 The contents of silica particles, V-P DMS, and H-P DMS in the coating liquid for forming the first layer are summarized in Tables 1 and 2 below.

また、 第 1層形成用の塗布液は、 シリカ粒子、 V—P DMS、 及び H— P D MSからなる固形分が 65質量%となるよう、 シクロペンタシロキサンに て希釈されている。 The coating liquid for forming the first layer was diluted with cyclopentasiloxane so that the solid content of silica particles, V-P DMS, and H-P D MS was 65% by mass.

[0083] 一塗布液の塗布及び乾燥一 [0083] One application and drying of the coating solution

第 1支持体として、 P ETフィルム表面にフロロシリコーン層を有する剥 離フィルム (フジコー社製、 型番 K 1、 厚み 5〇Mm) を準備した。 As the first support, a release film having a fluorosilicone layer on the surface of the PET film (manufactured by Fujiko, model number K1, thickness 50 Mm) was prepared.

第 1支持体のフロロシリコーン層上に、 所望の膜厚を得るために適切な塗 布量となるように厚みを調整して、 第 1層形成用の塗布液の塗布を行った。 なお、 塗布液の塗布は、 メチルヒドロシロキサンとジメチルシロキサンと の共重合体を添加してから 2分後に行った。 The coating liquid for forming the first layer was applied onto the fluorosilicone layer of the first support by adjusting the thickness so that the coating amount was appropriate to obtain a desired film thickness. The coating solution was applied 2 minutes after the copolymer of methylhydrosiloxane and dimethylsiloxane was added.

塗布後、 90°Cの送風乾燥機の中で 1時間乾燥処理することで、 シクロべ ンタシロキサンを除去して、 第 1層を形成した。 After application, the cyclopentasiloxane was removed by performing a drying treatment for 1 hour in a blast dryer at 90°C to form a first layer.

[0084] (第 1層の親水化処理) [0084] (Hydrophilic treatment of the first layer)

続いて、 第 1層の表面をコロナ処理し、 表面を親水化した。 コロナ処理装 置としては、 春日電機 (株) 製の T EC— 4 AXを使用した。 コロナ処理条 件は 0. 74 J/c m2で処理を行った。 Then, the surface of the first layer was subjected to corona treatment to make the surface hydrophilic. As the corona treatment device, TEC-4AX manufactured by Kasuga Electric Co., Ltd. was used. Corona treatment conditions were 0.74 J/cm 2 .

コロナ処理後の第 1層の表面と N M Pとの接触角は、 各例のすべてにおい て 60度以下であった。 なお、 コロナ処理後の第 1層の表面と NMPとの接 触角は、 既述の方法で測定した。 The contact angle between the surface of the first layer and NMP after corona treatment was 60 degrees or less in all cases. The contact angle between the surface of the first layer after corona treatment and NMP was measured by the method described above.

[0085] (第 2層の形成:シリコーン系粘着剤による第 2層の形成) (Formation of Second Layer: Formation of Second Layer with Silicone Adhesive)

シリコーン系粘着剤 (ダウコーニング社製、 B i o PSA 7 -4202 ) を酢酸エチルで希釈して、 第 2層形成用の塗布液とした。 A silicone adhesive (Bio PSA 7 -4202, manufactured by Dow Corning) was diluted with ethyl acetate to prepare a coating solution for forming the second layer.

なお、 第 2層形成用の塗布液中の各成分の含有量は、 下記表 1及び表 2に \¥0 2020/175681 28 卩(:171? 2020 /008363 The content of each component in the coating liquid for forming the second layer is shown in Tables 1 and 2 below. \\0 2020/175681 28 卩 (: 171? 2020 /008363

まとめた。 Summarized.

第 1層上に、 第 2層形成用の塗布液を、 所望の膜厚を得るために適切な塗 布量となるように厚みを調整して塗布し、 その後、 9 0 °〇の送風乾燥機の中 で 1 時間乾燥処理することで、 酢酸エチルを除去して、 第 2層を形成した。 Apply the coating liquid for forming the second layer on the first layer, adjusting the thickness so that the coating amount is appropriate to obtain the desired film thickness, and then drying with blowing air at 90 ° 〇. A second layer was formed by removing ethyl acetate by drying in a machine for 1 hour.

[0086] (第 2支持体の貼り合わせ) [0086] (Lamination of the second support)

第 2層上に、 巳丁フィルム表面にフロロシリコーン層を有する剥離フィ ルム (フジコー社製、 型番 [< 1、 厚み 5 0 ) を貼り合わせ、 積層体を得 た。 On the second layer, a release film having a fluorosilicone layer on the surface of the Mending film (manufactured by Fujico, model number [< 1, thickness 50) was attached to obtain a laminate.

[0087] [実施例 1 4 ] [0087] [Example 14]

第 2層の形成を、 以下のように変えた以外は、 実施例 1 〜 1 3と同様にし て、 実施例 1 4の積層体を得た。 A laminated body of Example 14 was obtained in the same manner as in Examples 1 to 13 except that the formation of the second layer was changed as follows.

[0088] (第 2層の形成: ゴム系粘着剤による第 2層の形成) (Formation of Second Layer: Formation of Second Layer with Rubber Adhesive)

熱可塑性エラストマーであるスチレンーイソプレンースチレンブロック共 重合体

Figure imgf000029_0001
(株) の 3 I 3 5 0 0 2 (商品名) ) 5 0質量部、 及び、 粘 着性付与剤として脂環族飽和炭化水素樹脂であるアルコン (登録商標)
Figure imgf000029_0002
Styrene-isoprene-styrene block copolymer, a thermoplastic elastomer
Figure imgf000029_0001
3 I 3500 2 (trade name)) 50 parts by mass, and Alcon (registered trademark) which is an alicyclic saturated hydrocarbon resin as an adhesiveness-imparting agent.
Figure imgf000029_0002

1 0 0 (荒川化学工業 (株) 製) 5 0質量部を容器に入れ、 シクロヘキサン (富士フイルム和光純薬 (株) 製) 及び酢酸エチル (富士フイルム和光純薬 (株) 製) の混合溶媒 (5 0質量%/ 5 0質量%) に溶解して、 ゴム系粘着 剤を用いた第 2層形成用の塗布液を調製した。 100 (manufactured by Arakawa Chemical Industry Co., Ltd.) 50 parts by mass was placed in a container, and a mixed solvent of cyclohexane (manufactured by FUJIFILM Wako Pure Chemical Industries, Ltd.) and ethyl acetate (manufactured by FUJIFILM Wako Pure Chemical Industries, Ltd.) (50% by mass/50% by mass) to prepare a coating liquid for forming the second layer using a rubber-based adhesive.

なお、 ゴム系粘着剤の調製に際しては、 熱可塑性エラストマーと粘着性付 与剤との総量がゴム系粘着剤の全質量に対して 1 5質量%となる量で、 上記 の混合溶媒に溶解し、 充分に撹拌を行った。 When preparing the rubber-based pressure-sensitive adhesive, the total amount of the thermoplastic elastomer and the tackiness-imparting agent is 15% by mass with respect to the total mass of the rubber-based pressure-sensitive adhesive, and is dissolved in the above mixed solvent. , Sufficiently stirred.

第 1層上に、 第 2層形成用の塗布液を所望の膜厚を得るために適切な塗布 量となるように厚みを調整して塗布し、 その後、 9 0 °〇の送風乾燥機の中で 1 時間乾燥処理することで、 上記の混合溶剤を除去して、 第 2層を形成した The coating liquid for forming the second layer is applied on the first layer by adjusting the thickness so as to obtain an appropriate coating amount to obtain a desired film thickness, and then applied by a blast dryer at 90° 〇. The above mixed solvent was removed by drying for 1 hour to form the second layer.

[0089] [実施例 1 5 ] [0089] [Example 15]

第 2層の形成を、 以下のように変えた以外は、 実施例 1 〜 1 3と同様にし \¥02020/175681 29 卩(:171? 2020 /008363 Same as Examples 1 to 13 except that the formation of the second layer was changed as follows. \¥02020/175681 29 卩 (: 171? 2020 /008363

て、 実施例 1 5の積層体を得た。 Thus, a laminate of Example 15 was obtained.

[0090] (第 2層の形成: アクリル系粘着剤による第 2層の形成) (Formation of Second Layer: Formation of Second Layer with Acrylic Adhesive)

アクリル系粘着剤として、 ヘンケル社の口 II 〇一丁八

Figure imgf000030_0001
87 -428 7 : アクリル酸 2 -エチルヘキシル ·酢酸ビニル · アクリル酸 2 -ヒドロキ シエチルコポリマー (架橋剤を含まず、 水酸基を有し、 且つカルボキシル基 を有さないアクリル系粘着剤) を、 粘着剤固形分の濃度が 20質量%になる ように酢酸エチル (富士フィルム和光純薬 (株) 製) に溶解し、 充分に撹拌 を行い、 第 2層形成用の塗布液を調製した。 As an acrylic adhesive, Henkel's mouth II 0-11-8
Figure imgf000030_0001
87 -428 7: 2-Ethylhexyl Acrylate-Vinyl Acetate-2-Hydroxyethyl Acrylate Copolymer (Acrylic adhesive that does not contain cross-linking agent, has hydroxyl group and does not have carboxyl group) It was dissolved in ethyl acetate (manufactured by Fuji Film Wako Pure Chemical Industries, Ltd.) so that the concentration of the solid content was 20% by mass, and sufficiently stirred to prepare a coating solution for forming the second layer.

第 1層上に、 第 2層形成用の塗布液を所望の膜厚を得るために適切な塗布 量となるように厚みを調整して塗布し、 その後、 90°〇の送風乾燥機の中で 1時間乾燥処理することで、 酢酸エチルを除去して、 第 2層を形成した。 The coating liquid for forming the second layer is applied on the first layer by adjusting the thickness so as to obtain an appropriate coating amount to obtain a desired film thickness, and then in a 90 ° blast dryer. Ethyl acetate was removed by drying for 1 hour to form a second layer.

[0091] [比較例·!〜 2] [0091] [Comparative example! ~ 2]

比較例 1 として、 テガダーム (登録商標、 スリーエムジャパン (株) 、 1 62 1、 1 0001X 1 20111) を用いた。 As Comparative Example 1, Tegaderm (registered trademark, 3M Japan KK, 1621, 1 0001X 1 20111) was used.

比較例 2として、 〇 丨 〇八一〇八[¾巳 (登録商標、 スミス · アンド ·ネフ ュー社、

Figure imgf000030_0002
製品番号 66250704) を用いた。 As Comparative Example 2, 〇丨 0801808 [¾mi (registered trademark, Smith & Nephew,
Figure imgf000030_0002
The product number 66250704) was used.

表 2中、 「第 1層と第 2層との総厚み」 の欄に記載の数値は、 比較例 1は 、 テガダームから剥離フィルムをはがした後の厚みであり、 比較例 2は、 〇 I 〇八一〇八 巳そのものの厚みである。 In Table 2, the numerical value shown in the column of “total thickness of the first layer and the second layer” is the thickness after peeling the release film from Tegaderm in Comparative Example 1, and in Comparative Example 2, It is the thickness of I 808.

[0092] [0092]

[¾1] [¾1]

Figure imgf000031_0001
Figure imgf000031_0001

[0093] \¥02020/175681 31 卩(:171? 2020 /008363 [0093] \¥02020/175681 31 卩(: 171? 2020/008363

[表 2] [Table 2]

Figure imgf000032_0001
Figure imgf000032_0001

[0094] [1 0%伸長時の引張応力、 40%伸長時の引張応力、 及び引張破断伸度の 測定] [0094] [Measurement of Tensile Stress at 10% Elongation, Tensile Stress at 40% Elongation, and Tensile Rupture Elongation]

各例における、 第 1層及び第 2層からなる積層物の、 1 0%伸長時の引張 \¥0 2020/175681 32 卩(:171? 2020 /008363 Tensile tension at 10% elongation of the laminate consisting of the first and second layers in each example \¥0 2020/175681 32 卩 (: 171? 2020 /008363

応力、 4 0 %伸長時の引張応力、 及び引張破断伸度を、 既述の方法で測定し た。 The stress, the tensile stress at 40% elongation, and the tensile elongation at break were measured by the methods described above.

なお、 比較例 1はテガダームについては粘着層に貼付けてある剥離フィル ムを外して幅 2

Figure imgf000033_0001
チャック間距離 4
Figure imgf000033_0002
になるように試験片を切り出 して、 また、 比較例
Figure imgf000033_0003
In Comparative Example 1, for Tegaderm, the peeling film attached to the adhesive layer was removed and the width was 2
Figure imgf000033_0001
Distance between chucks 4
Figure imgf000033_0002
The test piece was cut out so that
Figure imgf000033_0003

間距離 4〇 になるように試験片を切り出して、 4 0 %伸長時の引張応力 及び引張破断伸度を、 既述の方法で測定した The test piece was cut out so that the distance between them was 40, and the tensile stress at 40% elongation and the tensile elongation at break were measured by the method described above.

測定結果を表 1及び表 2に示す。 The measurement results are shown in Tables 1 and 2.

[0095] [追従性の評価] [0095] [Evaluation of followability]

3人のテスターの右手の手の甲に、 各例における積層体を 2 0 01 01 X 4 0 〇!に切り出してから、 第 1支持体及び第 2支持体を剥離し、 第 1層及び第 2層からなる積層物を貼付けた。 なお、 比較例 1はテガダームについては粘 着層に貼付けてある剥離フィルムを外して 2 0 ^1 01 X 4

Figure imgf000033_0004
に切り出して 、 3人のテスターの右手の手の甲に貼付けた。 また、 比較例 2は〇 丨 〇八_
Figure imgf000033_0005
り出して、 3人のテスターの右手 の手の甲に貼付けた。 Cut the laminated body in each example into 2 0 01 01 X 4 00! On the back of the right hand of 3 testers, then peel off the 1st support and the 2nd support, and the 1st layer and the 2nd layer. Was laminated. In Comparative Example 1, with regard to Tegaderm, the release film attached to the adhesive layer was removed to obtain 2 0 ^1 01 X 4
Figure imgf000033_0004
It was cut into pieces and attached to the backs of the right hands of the three testers. In addition, Comparative Example 2 is 〇丨 〇8_
Figure imgf000033_0005
It sticked out and stuck to the back of the right hand of the three testers.

3人のテスターに、 積層物の貼付けた箇所を動かしてもらい、 皮膚に感じ るつっぱり感を以下の 3段階で評価してもらった。 3人のテスターの評価点 を平均し、 これを追従性の評価結果とした。 We asked three testers to move the location where the laminate was applied, and evaluated the tension on the skin according to the following three grades. The evaluation points of the three testers were averaged, and this was taken as the evaluation result of the followability.

—つっぱり感の評価指標と評価点一 — Tension feeling evaluation index and evaluation score

つっぱり感を強く感じる : 1点 I feel a strong tension: 1 point

つっぱり感を僅かに感じる : 3点 Feel a slight tension: 3 points

つっぱり感を全く感じない : 5点 I don't feel any tension: 5 points

[0096] [違和感の評価] [0096] [Evaluation of discomfort]

3人のテスターの右手の手の甲に、 各例における積層体を 2 0 01 01 X 4 0 〇!に切り出してから、 第 1支持体及び第 2支持体を剥離し、 第 1層及び第 2層からなる積層物を貼付けた。 なお、 比較例 1はテガダームについては粘 着層に貼付けてある剥離フィルムを外して 2 0 ^1 01 X 4

Figure imgf000033_0006
に切り出して \¥0 2020/175681 33 卩(:171? 2020 /008363 Cut the laminated body in each example into 2 0 01 01 X 4 00! On the back of the right hand of 3 testers, then peel off the 1st support and the 2nd support, and the 1st layer and the 2nd layer. Was laminated. In Comparative Example 1, with regard to Tegaderm, the release film attached to the adhesive layer was removed to obtain 2 0 ^1 01 X 4
Figure imgf000033_0006
Cut out into \\0 2020/175681 33 卩 (: 171? 2020 /008363

、 3人のテスターの右手の手の甲に貼付けた。 また、 比較例 2は〇 丨 〇八_

Figure imgf000034_0001
り出して、 3人のテスターの右手 の手の甲に貼付けた。 , Affixed to the back of the right hand of three testers. In addition, Comparative Example 2 is 〇丨 〇8_
Figure imgf000034_0001
It sticked out and stuck to the back of the right hand of the three testers.

3人のテスターに、 積層物の貼付けた箇所について、 重さ及び異物感 (即 ち、 皮膚に異物が載っている感じ) を以下の 3段階で評価してもらった。 3 人のテスターの評価点を平均し、 これを異物感の評価結果とした。 Three testers evaluated the weight and the feeling of foreign matter (immediately, the feeling of foreign matter on the skin) at the location where the laminate was applied, according to the following three grades. The evaluation points of the three testers were averaged, and this was taken as the evaluation result of the feeling of foreign matter.

一重さ及び異物感の評価指標と評価点一 Evaluation index and evaluation score of weight and foreign body feeling

重さ及び異物感の少なくとも一方を強く感じる : 1点 Strongly feel at least one of weight and foreign body feeling: 1 point

重さ及び異物感の少なくとも一方を僅かに感じる : 3点 At least one of the weight and the feeling of foreign matter is slightly felt: 3 points

重さ及び異物感の少なくとも一方を全く感じない : 5点 At least one of the weight and the feeling of foreign matter is not felt at all: 5 points

[0097] [水蒸気透過性の評価] [Evaluation of Water Vapor Permeability]

3人のテスターの上腕の内側部に、 各例における積層体を 2 0 01 01 X 4 0 〇!に切り出してから、 第 1支持体及び第 2支持体を剥離し、 第 1層及び第 2層からなる積層物を貼付けた。 なお、 比較例 1はテガダームについては粘 着層に貼付けてある剥離フィルムを外して 2 0 ^1 01 X 4

Figure imgf000034_0002
に切り出して 、 3人のテスターの上腕の内側部に貼付けた。 また、 比較例 2は〇 丨 〇八一
Figure imgf000034_0003
り出して、 3人のテスターの上腕 の内側部に貼付けた。 The laminated body in each example was cut into 2 0 01 01 X 400 !!! on the inner side of the upper arms of the three testers, and then the first support and the second support were peeled off, and the first layer and the second support were separated. A laminate of layers was applied. In Comparative Example 1, with regard to Tegaderm, the release film attached to the adhesive layer was removed to obtain 2 0 ^1 01 X 4
Figure imgf000034_0002
It was cut out and attached to the inside of the upper arms of the three testers. In addition, Comparative Example 2 is 〇丨 〇81
Figure imgf000034_0003
It sticked out and stuck to the inside of the upper arms of the three testers.

3人のテスターに、 積層物の貼付けた箇所について、 2 4時間貼付した場 合の蒸れを以下の 3段階で評価してもらった。 3人のテスターの評価点を平 均し、 これを水蒸気透過性の評価結果とした。 We asked three testers to evaluate the degree of stuffiness on the part where the laminate was applied for 24 hours, using the following three grades. The evaluation points of the three testers were averaged and used as the evaluation results of water vapor permeability.

-蒸れの評価指標と評価点一 -Evaluation index and evaluation score of stuffiness

蒸れを強く感じる : 1点 Feeling stuffy: 1 point

蒸れを僅かに感じる : 3点 Slight stuffiness: 3 points

蒸れを全く感じない : 5点 No stuffiness: 5 points

[0098] 表 1〜表 2の結果より、 実施例の積層体は、 皮膚に貼付けた際に、 いずれ も、 追従性に優れ、 違和感もなく、 更に、 水蒸気透過性にも優れることが分 かった。 \¥02020/175681 34 卩(:171? 2020 /008363 [0098] From the results of Tables 1 and 2, it can be seen that the laminates of Examples all have excellent conformability, no discomfort when attached to the skin, and also excellent water vapor permeability. It was \¥02020/175681 34 卩 (: 171? 2020 /008363

[0099] 201 9年 2月 28日に出願された日本出願特願 201 9-036430 の開示はその全体が参照により本明細書に取り込まれる。 [0099] The disclosure of Japanese Patent Application No. 201 9-036430 filed on Feb. 28, 2010 is incorporated herein by reference in its entirety.

本明細書に記載された全ての文献、 特許出願、 及び技術規格は、 個々の文 献、 特許出願、 及び技術規格が参照により取り込まれることが具体的かつ個 々に記された場合と同程度に、 本明細書中に参照により取り込まれる。 All references, patent applications, and technical standards mentioned in this specification are to the same extent as if each individual document, patent application, and technical standard were specifically and individually noted to be incorporated by reference. , Incorporated herein by reference.

Claims

\¥0 2020/175681 35 卩(:17 2020 /008363 請求の範囲 \¥0 2020/175681 35 卩(: 17 2020/008363 Claims [請求項 1 ] シリコーンエラストマーを含む第 1層と、 第 1層と接触し且つ粘着 性を示す第 2層と、 を有し、 [Claim 1] has a first layer containing a silicone elastomer, and a second layer in contact with the first layer and exhibiting adhesiveness, 第 1層と第 2層との積層物は、 4 0 %伸長時の引張応力が 0 . 8 !\/1 8以下であり、 且つ、 総厚みが 1 111 111以下である、 皮膚貼付け用積層体。 The laminate of the first layer and the second layer has a tensile stress at 40% elongation of 0.8 !\/18 or less and a total thickness of 11 11 111 or less, and is a laminate for skin application. body. [請求項 2] 第 1層と第 2層との積層物の引張破断伸度が 1 0 0 %以上である、 請求項 1 に記載の皮膚貼付け用積層体。 [Claim 2] The laminate for skin application according to claim 1, wherein the tensile breaking elongation of the laminate of the first layer and the second layer is 100% or more. [請求項 3] 第 1層がシリカ粒子を含む、 請求項 1又は請求項 2に記載の皮膚貼 付け用積層体。 [Claim 3] The laminate for skin application according to claim 1 or 2, wherein the first layer contains silica particles. [請求項 4] シリカ粒子の含有量が第 1層の全質量に対して 7質量%〜 3 0質量 [Claim 4] The content of silica particles is 7% by mass to 30% by mass with respect to the total mass of the first layer. %である、 請求項 3に記載の皮膚貼付け用積層体。 % Of the laminated body for skin application according to claim 3. [請求項 5] シリコーンエラストマーがヒドロシリル化反応による架橋構造を有 する、 請求項 1〜請求項 4のいずれか 1項に記載の皮膚貼付け用積層 体。 [Claim 5] The laminate for skin application according to any one of claims 1 to 4, wherein the silicone elastomer has a crosslinked structure by a hydrosilylation reaction. [請求項 6] 第 1層の第 2層と接する面とは反対の面側に接する第 1支持体と、 第 2層の第 1層と接する面とは反対の面側に接する第 2支持体と、 を 更に有する、 請求項 1〜請求項 5のいずれか 1項に記載の皮膚貼付け 用積層体。 [Claim 6] The first support contacting the surface of the first layer opposite to the surface in contact with the second layer, and the second support contacting the surface of the second layer opposite to the surface in contact with the first layer. A laminate for skin application according to any one of claims 1 to 5, further comprising: a body. [請求項 7] 第 1支持体の第 1層側の面及び第 2支持体の第 2層側の面の少なく とも一方がシリコーン層を有する又はシリコーンにより表面処理され ている、 請求項 6に記載の皮膚貼付け用積層体。 [Claim 7] At least one of the first layer side surface of the first support and the second layer side surface of the second support has a silicone layer or is surface-treated with silicone. The laminated body for skin application as described above. [請求項 8] 生体モニタリングデバイス、 表示素子、 創傷被覆材、 経皮製剤、 又 は化粧品に用いる、 請求項 1〜請求項 7のいずれか 1項に記載の皮膚 貼付け用積層体。 [Claim 8] The laminate for skin application according to any one of claims 1 to 7, which is used for a biological monitoring device, a display element, a wound dressing, a transdermal preparation, or a cosmetic. [請求項 9] シリコーンエラストマーを含む第 1層を形成する工程八と、 [Claim 9] Step 8 of forming a first layer containing a silicone elastomer, 粘着性を有する第 2層を形成する工程巳と、 A step of forming a second layer having adhesiveness, を有し、 \¥0 2020/175681 36 卩(:171? 2020 /008363 Have \¥0 2020/175681 36 卩 (: 171? 2020 /008363 第 1層と第 2層との積層物の 4 0 %伸長時の引張応力が〇. 8 1\/1 3以下であり、 且つ、 総厚みが 1
Figure imgf000037_0001
以下である、 皮膚貼付け用積層 体の製造方法。
The tensile stress at 40% elongation of the first layer and second layer laminate is less than 0.81\/13 and the total thickness is 1
Figure imgf000037_0001
The following is a method for producing a laminate for skin application.
[請求項 10] 工程八が、 第 1支持体上に、 架橋性基を有するシリコーンポリマー 、 架橋剤、 及び溶剤を含む塗布液を塗布及び乾燥させて、 第 1層を形 成する工程である、 請求項 9に記載の皮膚貼付け用積層体の製造方法 [Claim 10] Step 8 is a step of forming a first layer by coating and drying a coating liquid containing a silicone polymer having a crosslinkable group, a crosslinking agent, and a solvent on the first support. A method for manufacturing the laminate for skin application according to claim 9. [請求項 1 1 ] 工程八が、 第 1支持体上に、 架橋性基を有するシリコーンポリマー 、 架橋剤、 シリカ粒子、 及びシリコーン系溶剤を含む塗布液を塗布及 び乾燥させて、 第 1層を形成する工程である、 請求項 9に記載の皮膚 貼付け用積層体の製造方法。 [Claim 11] In Step 8, a coating liquid containing a silicone polymer having a crosslinkable group, a crosslinking agent, silica particles, and a silicone-based solvent is applied and dried on the first support to form a first layer. The method for producing a laminate for skin application according to claim 9, which is a step of forming a skin. [請求項 12] 工程巳が、 第 1層上に第 2層を形成する工程である、 請求項 9〜請 求項 1 1のいずれか 1項に記載の皮膚貼付け用積層体の製造方法。 [Claim 12] The method for producing a skin patch laminate according to any one of claims 9 to 11, wherein the step A is a step of forming a second layer on the first layer. [請求項 13] 連続搬送される第 1支持体を用い、 口ールトゥロール方式にて工程 八及び工程巳が行われる、 請求項 9〜請求項 1 2のいずれか 1項に記 載の皮膚貼付け用積層体の製造方法。 [Claim 13] For skin sticking according to any one of claims 9 to 12, wherein step 8 and step 9 are performed by a mouth-to-roll method using a continuously transported first support. Method for manufacturing laminated body. [請求項 14] 工程八と工程巳との間に、 [Claim 14] Between step 8 and step 工程八にて形成された第 1層の表面に保護フィルムを貼り合わせる 工程八 1、 及び、 貼り合された保護フィルムを第 1層の表面から剥離 する工程 2と、 を更に含む、 請求項 9〜請求項 1 3のいずれか 1項 に記載の皮膚貼付け用積層体の製造方法。 The method according to claim 9, further comprising the step of adhering a protective film to the surface of the first layer formed in step 8, 1 and the step of peeling the adhered protective film from the surface of the first layer. ~ A method for manufacturing the laminate for skin application according to any one of claims 13 to 13. [請求項 15] 工程八と工程巳との間に、 工程八にて形成された第 1層の表面を親 水化処理する工程 3を更に含む、 請求項 9〜請求項 1 4のいずれか 1項に記載の皮膚貼付け用積層体の製造方法。 [Claim 15] The method according to any one of claims 9 to 14, further comprising a step 3 of performing a hydrophilization treatment on the surface of the first layer formed in the step 8, between the step 8 and the step. The method for producing a laminate for skin application according to item 1. [請求項 16] 工程八 3にて親水化処理された第 1層の表面は、 1\1 -メチルー 2 - ピロリ ドンとの接触角が 6 0度以下である、 請求項 1 5に記載の皮膚 貼付け用積層体の製造方法。 [Claim 16] The surface of the first layer hydrophilized in step 83 has a contact angle with 1\1-methyl-2-pyrrolidone of 60° or less, according to claim 15 A method for producing a laminate for skin application. [請求項 17] 工程巳後、 第 2層上に第 2支持体と貼り合わせる工程 0を更に有す \¥0 2020/175681 37 卩(:17 2020 /008363 る、 請求項 9〜請求項 1 6のいずれか 1項に記載の皮膚貼付け用積層 体の製造方法。 [Claim 17] The method further comprises a step 0 of laminating the second support on the second layer after the step. \0 2020/175681 37 (: 17 2020/008363) The method for producing a skin patch laminate according to any one of claims 9 to 16.
PCT/JP2020/008363 2019-02-28 2020-02-28 Layered body for skin adhesion and method for producing same Ceased WO2020175681A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019-036430 2019-02-28
JP2019036430 2019-02-28

Publications (1)

Publication Number Publication Date
WO2020175681A1 true WO2020175681A1 (en) 2020-09-03

Family

ID=72239752

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2020/008363 Ceased WO2020175681A1 (en) 2019-02-28 2020-02-28 Layered body for skin adhesion and method for producing same

Country Status (1)

Country Link
WO (1) WO2020175681A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023045146A (en) * 2021-09-21 2023-04-03 大日本印刷株式会社 LAMINATED SHEET, SKIN DESIGN SHEET, AND SKIN DESIGN SHEET MANUFACTURING METHOD

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000217858A (en) * 1999-01-27 2000-08-08 Nitto Denko Corp Medical adhesive tape or sheet, and first aid bandage
JP2008525557A (en) * 2004-12-23 2008-07-17 ロディア・シミ Non-yellowing silicone composition
JP2009149844A (en) * 1996-12-23 2009-07-09 Wyeth Adhesive for secure topical attachment to the skin and comfortable removal
JP2010132350A (en) * 2008-10-01 2010-06-17 Nippon Electric Glass Co Ltd Glass roll and glass roll processing method
JP2016529206A (en) * 2013-05-10 2016-09-23 ザ プロクター アンド ギャンブル カンパニー Consumer products containing silane-modified oil
JP2017506125A (en) * 2014-02-19 2017-03-02 スイス ファウイクス フェーネンテラピー ウント フォルシュング ゲゼルシャフト ミット ベシュレンクテル ハフツング Adhesive film bandage for medical compression
JP2018197213A (en) * 2017-05-24 2018-12-13 バンドー化学株式会社 Patch
JP2018201751A (en) * 2017-06-01 2018-12-27 株式会社グランブルー Concealing sheet

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009149844A (en) * 1996-12-23 2009-07-09 Wyeth Adhesive for secure topical attachment to the skin and comfortable removal
JP2000217858A (en) * 1999-01-27 2000-08-08 Nitto Denko Corp Medical adhesive tape or sheet, and first aid bandage
JP2008525557A (en) * 2004-12-23 2008-07-17 ロディア・シミ Non-yellowing silicone composition
JP2010132350A (en) * 2008-10-01 2010-06-17 Nippon Electric Glass Co Ltd Glass roll and glass roll processing method
JP2016529206A (en) * 2013-05-10 2016-09-23 ザ プロクター アンド ギャンブル カンパニー Consumer products containing silane-modified oil
JP2017506125A (en) * 2014-02-19 2017-03-02 スイス ファウイクス フェーネンテラピー ウント フォルシュング ゲゼルシャフト ミット ベシュレンクテル ハフツング Adhesive film bandage for medical compression
JP2018197213A (en) * 2017-05-24 2018-12-13 バンドー化学株式会社 Patch
JP2018201751A (en) * 2017-06-01 2018-12-27 株式会社グランブルー Concealing sheet

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023045146A (en) * 2021-09-21 2023-04-03 大日本印刷株式会社 LAMINATED SHEET, SKIN DESIGN SHEET, AND SKIN DESIGN SHEET MANUFACTURING METHOD
JP7771588B2 (en) 2021-09-21 2025-11-18 大日本印刷株式会社 Skin design sheet and skin design sheet manufacturing method

Similar Documents

Publication Publication Date Title
JP3717952B2 (en) Medical adhesive and medical dressing material having the same
EP2877135B1 (en) Silicone/acrylic hybrid adhesives
JP2002069405A (en) Adhesive composition and adhesive tape or sheet
EP1684814B1 (en) Method for adhering silicone gels to plastics
JP2001527445A (en) Textured matte finish, low adhesion backsize coating
CN103561785A (en) Pressure sensitive adhesive for application on skin and process for the production thereof
KR101367168B1 (en) Article or component of a medical and technical nature for affixing a medical article or part therof to skin, provided with a releasable protection layer
CN1331540C (en) Pressure-sensitive adhesive sheet for application to skin and first-aid plaster
JP5246838B2 (en) Keratin peeling adhesive composition and keratin peeling adhesive sheet
WO2020175681A1 (en) Layered body for skin adhesion and method for producing same
WO2023144077A1 (en) Medical article for fixation of a wound dressing
TWI855043B (en) Tie layer chemistry to promote bonding with silicone adhesive
JP2006230930A (en) Pasting material
CN114450368A (en) Film backing for peelable securement
EP4010037A1 (en) Low trauma wound dressings and adhesives for same
CN112351759A (en) Adhesive material for body surface
JP2016084444A (en) Acrylic adhesive less in keratin detachment
US20150182383A1 (en) Silicone/Acrylic Hybrid Adhesives
JP2002248124A (en) Medical patches and emergency bandages
CN113853414B (en) Medical adhesive material
JPH11349476A (en) Medical pasting material
JP4638480B2 (en) Medical bandage for application on the skin
JPH09206369A (en) Skin patch and first aid bandage
JP2000225185A (en) First aid bandage
JP2009102304A (en) Self-adhesive for corneocyte exfoliation and method for beauty treatment

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20763787

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20763787

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP